CN101801981A - Plucked instrument soil is because of modulability thiazole and pyridine compounds - Google Patents

Abstract

The invention provides new plucked instrument soil because of (sirtuin)-modulating compound and utilize method.Plucked instrument soil can be used for increasing cell survival because of-modulating compound, and treat and/or prevent various diseases and deficiency disorder, comprise, for example with aging or pressure diseases associated or deficiency disorder, diabetes, obesity, neurodegenerative disease, cardiovascular disorder, coagulation of blood deficiency disorder, inflammation, cancer and/or flush, and can be because of increasing disease or the deficiency disorder that mitochondria activity benefits.The present invention also provides and comprises the plucked instrument soil composition because of-modulating compound and combination with other therapeutic agents.

Description

Plucked instrument soil is because of modulability thiazole and pyridine compounds

Related application

The application requires the rights and interests of the U.S. Provisional Application 60/936,636 of submission on June 20th, 2007, and the content of this provisional application is introduced the application as a reference in full.

Background

Silent message conditioning agent (Silent Information Regulator) (SIR) gene family representative is present in the high conservative gene (Fu Laier (Frye), 2000) of scope from archeobacteria to the genome of various Eukaryotic organisms.The SIR protein of coding relates to the various distinct programs that DNA repairs that are adjusted to from gene silencing.Show by many SIR gene family encoded protein matter: the sequence high conservative in 250 amino acid Core Feature territories.In this family quite the gene of characterization be Saccharomyces Cerevisiae in S IR2, it relates to silence and contains HM locus (Gua Lunti (Guarente), 1999 of specifying yeast mating type, telomere position effect and cell senescence information; Ka Bailaien people such as (Kaeberlein), 1999; Repair auspicious (Shore), 2000).Yeast Sir2 protein belongs to histone deacetylase family and (summarizes in the melon human relations and carry, 2000; Repair auspicious, 2000).Sir2 homologue (homolog) in the Salmonella typhimurium (CobB), function is as NAD (Reduced nicotinamide-adenine dinucleotide)-dependency ADP-ribosyltransferase (normal (Tsang) carries-Xi Moruina (Escalante-Semerena) 1998 with ACunico indigo plant).

Sir2 protein is for using III class deacetylase (modern well people such as (Imais), 2000 of NAD as cosubstrate; Mo Cui gets (Moazed), 2001; Smith people such as (Smith), 2000; Tower Nellie people such as (Tanner), 2000; Tower Buddhist nun (Tanny) with do not come together 2001).Be different from other deacetylases, the many gene silencings that relate in these, Sir2 are to I and II class histone deacetylase inhibitors, and for example trichostatin (trichostatin) A (TSA) is not had susceptibility (people such as modern well, 2000; The indigo plant people such as (Landry) that gets profit, 2000a; People such as Smith, 2000).

The deacetylationization of the ethanoyl-Methionin that is undertaken by Sir2 is combined closely with the NAD hydrolytic action, produces niacinamide and new ethanoyl-ADP ribose compound (people such as tower Nellie, 2000; Indigo plant people such as get profit, 2000b; The tower Buddhist nun with do not come together 2001).The NAD-dependency deacetylation enzymic activity of Sir2 is for its biology role necessary activity (Gua Lunti, 2000 for zymic cellular metabolism effect combines this its function; People such as modern well, 2000; Woods people such as (Lin), 2000; People such as Smith, 2000).Mammals Sir2 homologue has NAD-dependency histone deacetylase activity (people such as modern well, 2000; People such as Smith, 2000).About research (Jia Dunbaige (Gartenberg), 2000 of carrying out in the next comfortable yeast of most of information of function that Sir2 mediates; Ancient woods (Gottschling), 2000 of being permitted).

Biochemical research shows that Sir2 can cause forming 1-O-ethanoyl-ADP-ribose and niacinamide easily with the N-terminal afterbody deacetylationization of histone H 3 and H4.Bacterial strain with extra SIR2 copy shows reticent increase of its rDNA and ILS 30%.Show that recently the additional copy of Caenorhabditis elegans (C.elegans) SIR2 homologue (sir-2.1) and fruit bat (D.Melanogaster) dSir2 gene can prolong the life-span of these organisms greatly.This hint is regulated approach at aged SIR2-dependency, and it has occurred in early days and quite guarded developing.Now, believe that the Sir2 gene develops,, increase the chance that it tides over the survival adverse circumstance with health and the crushing resistance of improving organism.

SIRT3 is the homologue of SIRT1, and it is tool conservative property (P. father-in-law poplar brother people such as (Onyango), Proc.Natl.Acad.Sci.USA 99:13653-13658 (2002)) in prokaryotic organism and eukaryote.The unique function territory target of SIRT3 albumen by being positioned at the N-end is surely to mitochondrial ridge (mitochondrialcristae).SIRT3 has NAD+-dependence protein matter deacetylation enzymic activity, and is expressed at large, particularly, has in the tissue of metabolic activity.When being transferred to plastosome, believe that SIRT3 is cracked into less, the active form of tool (B. is permitted Weir people such as (Schwer), J.Cell Biol.158:647-657 (2002)) by mitochondrial matrix processing peptidase (MPP).

Calorie restriction (caloric restriction) has been used for more than 70 years old, to improve health and to prolong the Mammals life-span (Ma Suoluo (Masoro), 2000).The life-span of yeast (as metazoan) also prolongs by the mediation of similar calorie of restriction (for example low dextrose).Find to lack the yeast and the fly class of SIR2 gene, when no longer survival when calorie limits, this effect good for health for this type of diet of SIR2 gene mediated provides evidence (An Dexun people such as (Anderson), 2003; He Fangde (Helfand) and Luo Jina (Rogina), 2004).And, reduction yeast glucose-responsiveness cAMP (adenosine 3 ', 5 '-single phosphoric acid)-the active sudden change of dependency (PKA) approach, meeting prolongs the life-span of wild-type cell but then can not prolong cell survival in mutant sir2 bacterial strain, this has proved the SIR2 crucial downstream component (Lin Dengren, 2001) of calorie restriction approach seemingly.

Summary of the invention

The invention provides new plucked instrument soil because of (sirtuin)-modulating compound and utilize method.

On the one hand, the invention provides the plucked instrument soil that has structural formula (I)-(VI) as described in more detail below because of-modulating compound.

On the other hand, the invention provides and use plucked instrument soil, or comprise the native method for compositions of plucked instrument because of-modulating compound because of-modulating compound.In some specific embodiments, increase plucked instrument soil and can be used for various treatments application because of-modulating compound because of proteinic level and/or active plucked instrument soil, comprise, for example increase cell survival, treat and/or prevent many various diseases and deficiency disorder, comprise, for example with aging or pressure diseases associated or deficiency disorder, diabetes, fat, neurodegenerative disease, the neuropathy that chemotherapy is brought out, with the relevant neuropathy of ischemia incident (ischemic event), eye disease and/or deficiency disorder, cardiovascular disorder, the coagulation of blood deficiency disorder, inflammation, and/or flush etc.Increasing plucked instrument soil also can be used for treating because of-modulating compound because of proteinic level and/or active plucked instrument soil, can be in the individuality because of increasing disease or the deficiency disorder that mitochondria activity benefits, be used to promote muscle function, be used to increase muscle ATP level, or be used for the treatment of or muscle tissue damage that prevention is relevant with anoxic or ischemic.In other specific embodiments, reduce plucked instrument soil and can be used for various treatments application because of-modulating compound because of proteinic level and/or active plucked instrument soil, comprise, for example increase cell to the susceptibility of pressure, increase apoptosis, treatment cancer, stimulate appetite and/or stimulate weight increase etc.As hereinafter further narration, these methods comprise that pharmaceutically the plucked instrument of significant quantity is native because of-modulating compound to individual administration that needs are arranged.

In some aspects, plucked instrument soil because of-modulating compound can be independent, or comprises that with other compounds other plucked instrument are native because of-modulating compound, or combination with other therapeutic agents is carried out administration.

Detailed Description Of The Invention

1. definition

Definition as described herein, that following term and phrase should have hereinafter to be narrated.Unless otherwise defined, all technology used herein and scientific terminologies have the general identical definition of understanding with those of ordinary skills.

Singulative " one ", " a kind of " reach " being somebody's turn to do " and comprise plural scope, unless Wen Zhongyou clearly indication in addition.

Term " reagent " is used for the mixture, biomacromolecule (for example nucleic acid, antibody, protein or its part for example peptide class) of this paper middle finger chemical compound, chemical compound or from the biomaterial extract that makes of bacterium, plant, fungi or animal (particularly Mammals) cell or tissue for example.The activity of this type of reagent make they be suitable for as tool biologically, on the physiology or pharmaceutically active be used for individual in part or general carry out " therapeutical agent " of its effect.

Term " biological available " is when citation one compound, be those of ordinary skills' cognitions, and mean compound its (or some amounts of the compound that gives) and can be absorbed, incorporate into or otherwise on physiology, be utilized by the individuality of institute's administration or patient.

" plucked instrument soil because of the active part of tool biologically " means biologically active, and the part plucked instrument soil that for example has the deacetylation ability is because of albumen.Plucked instrument soil because of the active part of tool biologically can comprise plucked instrument soil because of the Core Feature territory.Have GenBank login numbering NP_036370 SIRT1 biologically have an active part, comprise NAD+ combined function territory and substrate combined function territory, for example can be including but not limited to the amino acid 62-293 of GenBank login numbering NP_036370, it is coded by the Nucleotide 237 to 932 of GenBank login numbering NM_012238.Therefore, this zone is known as the Core Feature territory sometimes.The other biological of SIRT1 is learned and is gone up the amino acid 261 to 447 that tool active part (also being known as the Core Feature territory sometimes) comprises GenBank login numbering NP_036370, and it is coded by the Nucleotide 834 to 1394 of GenBank login numbering NM_012238; The amino acid 242 to 493 of GenBank login numbering NP_036370, it is coded by the Nucleotide 777 to 1532 of GenBank login numbering NM_012238; Or the amino acid 254 to 495 of GenBank login numbering NP_036370, it is coded by the Nucleotide 813 to 1538 of GenBank login numbering NM_012238.

Term " companion animals " is meant cat and dog.As being used for this paper, term " dog " means arbitrary member of Canidae species, and many different varietiess are wherein arranged.Term " cat " means feline, and comprising feeds keeps a cat and other members of cat family Felis.

Term " comprises " and reaches " comprising " and be used for blanket property, open definition, means to comprise additional element.

" diabetes " mean hyperglycemia or ketoacidosis, and because of hyperglycemia state or glucose tolerance lower caused chronic, general metabolic disturbance for a long time." diabetes " comprise the I and II type (non-insulin-dependent diabetes mellitus (NIDDM) or the NIDDM) form of this disease.The risk factor of diabetes comprises the following factor: man's waistline surpasses 40 inches or woman's waistline above 35 inches, blood pressure be 130/85mmHg or more than, tri-glyceride is higher than 150mg/dl, fasting plasma glucose is greater than 100mg/dl, or man's middle-high density lipoprotein is less than among 40mg/dl or the woman and is less than 50mg/dl.

Plucked instrument soil because of " direct activation agent " for making plucked instrument soil because of the activatory molecule by combining with it.Plucked instrument soil because of " directly inhibitor " for by combine with it suppress plucked instrument native because of molecule.

Term " ED ₅₀" be that those of ordinary skills approve.In some specific embodiments, ED ₅₀Mean the dosage that medicine produces 50% maximum reaction or effect, perhaps in 50% test individuality or preparation, produce the dosage of predetermined reaction.Term " LD ₅₀" be that those of ordinary skills approve.In some specific embodiments, LD ₅₀Mean medicine and make the individual lethal dosage of 50% test.Term " therapeutic index " is that those of ordinary skills approve, is meant the therapeutic index of medicine, is defined as LD ₅₀/ ED ₅₀

Term " hyperinsulinemia " means the situation that blood insulin level in the individuality is higher than normal value.

Term " comprise " and be used to mean " including but not limited to "." comprise " with " including but not limited to " can exchange use mutually.

Term " insulin resistance " means, and wherein normal amount Regular Insulin produces compared to the biological respinse in the individuality that does not have insulin resistance, is the state of subnormal biological respinse.

" insulin resistance deficiency disorder " (discussing as this paper) means, and produces or come from any disease or the patient's condition that insulin resistance causes.Example comprises: diabetes, fat, metabolism syndrome (syndromes), insulin resistance syndrome, syndrome X (syndromes X), insulin resistance, hypertension, hyperpiesia, high blood cholesterol, dyslipidemia, hyperlipidemia, dyslipidemia, atheromatosis comprises apoplexy, coronary artery disease or myocardial infarction, hyperglycemia, high blood insulin disease and/or high blood Proinsulin disease, glucose tolerance weakens, postponing Regular Insulin disengages, diabetic complication comprises coronary heart disease, stenocardia, congestive heart failure, apoplexy, dull-witted cognitive function, retinopathy, the periphery neuropathy, neuropathy, glomerulonephritis, glomerulosclerosis, nephrotic syndrome, hypertensive nephrosclerosis, some types of cancer (carcinoma of endometrium for example, breast cancer, prostate cancer and colorectal carcinoma), pregnancy complications, the healthy variation of female reproduction (irregular menses for example, infertile, irregular ovulation, polycystic ovary syndrome (PCOS)), lipodystrophy, cholesterol related disorder disease (cholelith for example, cholecystitis and chololithiasis), gout, obstacle sleep apnea and breathing problem, osteoarthritis, and prevent and treat for example osteoporosis of bone-loss.

Term " livestock animals " is meant the tetrapods through raising and train, comprise that those are meat and all kinds of byproduct domesticated animal, for example bovine comprises ox and other Bos member, porcine animals comprises feeding raises pigs and other pig genus members, sheep class animal comprises that sheep and other sheep belong to the member, feed goat and other Capras member; For particular task is for example used the tetrapods of raising as heavy burden through raising and train, for example horse class animal comprises horse and other equine Equus members.

Term " Mammals " is that those of ordinary skills are known, and exemplary Mammals comprises the mankind, primates, livestock animals (comprising bovine, Swine etc.), companion animals (for example dog class, cat class etc.) and rodents (for example mouse and rat).

" obesity " is individual or bear the bitter individuality of obesity, generally is that health weight index (BMI) is at least 25 or above individuality.The obesity insulin resistance of may maybe may getting along well is relevant.

It is what those of ordinary skills approved that term " parenteral administration " reaches " parenteral ground carries out administration ", be meant the form of medication except for oral administration and topical, generally be through injection, and comprise in (but being not limited to) intravenously, intramuscular, intra-arterial, sheath, in the capsule, interior, intracardiac, the intradermal of eye socket, intraperitoneal, under tracheae, subcutaneous, epidermis, under the intraarticular, capsule, under the arachnoid membrane, in the backbone with breastbone inner injection and perfusion administration.

" patient ", " entity ", " individuality " or " host " are meant the mankind or non-human animal.

Term " pharmaceutically acceptable carrier " is what those of ordinary skills approved, be meant to relate to pharmaceutically acceptable material, constituent or the media that carries or transport any main body constituent or its composition, for example liquid or solid weighting agent, thinner, vehicle, solvent or seal material.Each carrier just is necessary for " can accept " forming with main body constituent or its with regard to the compatible meaning, and harmless to the patient.Some examples that can be provided as the material of pharmaceutically acceptable carrier comprise: (1) carbohydrate, for example lactose, glucose and sucrose; (2) starch, for example W-Gum and yam starch; (3) Mierocrystalline cellulose and its derivative, for example Xylo-Mucine, ethyl cellulose and cellulose acetate; (4) tragacanth gum of powdered; (5) Fructus Hordei Germinatus; (6) gelatin; (7) talcum; (8) vehicle, for example theobroma oil and suppository wax; (9) oils, for example peanut oil, Viscotrol C, Trisun Oil R 80, sesame oil, sweet oil, Semen Maydis oil and soybean oil; (10) glycols, for example propylene glycol; (11) polyalcohols, for example glycerine, Sorbitol Powder, mannitol and polyoxyethylene glycol; (12) ester class, for example ethyl oleate and Laurate ethyl; (13) agar; (14) buffer reagent, for example magnesium hydroxide and aluminium hydroxide; (15) alginic acid; (16) apirogen water; (17) etc. open salt solution; (18) Ringer's solution; (19) ethanol; (20) phosphate buffer soln; Other are used for the compatible material of nontoxicity of pharmaceutical preparation to reach (21).

Term " preventative " or " therapeutic " treatment are meant to give the host with medicine for the term of those of ordinary skills' approval.If (for example manifest undesirable patient's condition clinical; the disease of host animal or other undesirable states) carry out administration before; then this treatment is preventative; promptly protect the host can not develop into this undesirable patient's condition; if and carry out administration in clinical manifesting after not wishing the patient's condition, then this treatment be therapeutic (promptly desire reduce, improve or keep existing do not wish the patient's condition or by the side effect of its generation).

During term " pyrogen-free (pyrogen-free) " citation composition, mean do not contain its content can be at the composition that in the individuality of said composition administration, causes deleterious effect (for example, stimulation, heating, inflammation, diarrhoea, RD, endotoxin shock etc.).For example, this term is intended to comprise and does not contain (or not containing in fact) such as (for example) lipopolysaccharides endotoxic compositions such as (LPS).

" duplicating the life-span (replicative lifespan) " of cell means the daughter cell number that is produced by indivedual " maternal cell ".On the other hand, " timeliness aging " or " timeliness life-span " means cell in the non-division of a group still keep the time span of surviving when quilt is deprived nutrient." increase cell survival " or " prolongation cell survival " means increase by daughter cell number that single cell produced when being applied to cell or organism; Increase the ability that cell or organism counter pressure reach and damage (for example to DNA, proteinic damage) is fought; And/or increase cell or organism can be in special conditions of contract, for example pressure (as heat-shocked, seepage water pressure, high energy radiation, chemical induction pressure, dna damage, unsuitable salt level, unsuitable nitrogen level or insufficient nutrient level) survival or have the more ability of long period down with the state of living.Use described method herein, the life-span can increase at least about 20%, 30%, 40%, 50%, 60%, or between 20% to 70%, 30% to 60%, 40% to 60% or more than.

" plucked instrument soil because of-reactivity compound " (sirtuin-activating compound) means plucked instrument soil increased because of protein level, and/or increase plucked instrument soil is because of at least a active compound of protein.In exemplary specific embodiments, plucked instrument soil can make plucked instrument soil because of proteinic at least a biological activity because of-reactivity compound, increase at least about 10%, 25%, 50%, 75%, 100% or more than.Plucked instrument soil comprises the deacetylationization of (for example) histone and p53 because of proteinic exemplary biological activity; Prolongs life; Increase genomic stability; Reticent Transcription; And the separating between regulation and control maternal cell and daughter cell through oxidized protein.

" plucked instrument soil because of-inhibition compound " means plucked instrument soil is reduced because of protein level, and/or attenuating plucked instrument soil is because of at least a active compound of protein.In exemplary specific embodiments, plucked instrument soil because of-inhibition compound can make plucked instrument soil because of proteinic at least a biological activity attenuating at least about 10%, 25%, 50%, 75%, 100% or more than.Plucked instrument soil comprises the deacetylationization of (for example) histone and p53 because of proteinic exemplary biological activity; Prolongs life; Increase genomic stability; Reticent Transcription; And the separating between regulation and control maternal cell and daughter cell through oxidized protein.

" plucked instrument soil because of-modulating compound " means the compound of structural formula (I)-(VI) as described herein.In exemplary specific embodiments, but plucked instrument soil is regulated (for example suppress or suppress) or is not so changed plucked instrument soil because of proteinic functional performance or biological activity because of-modulating compound incremental adjustments (for example activation or stimulate), decrement.Plucked instrument soil can act on direct or indirect adjusting plucked instrument soil because of protein because of-modulating compound.In some specific embodiments, plucked instrument soil is native because of-inhibition compound because of-reactivity compound or plucked instrument because of-modulating compound can be plucked instrument soil.

" plucked instrument soil is because of protein " means plucked instrument soil because of the member of (or preferably referring to sir2 family) of deacetylation zymoprotein family, comprises yeast Sir2 (GenBank login numbering P53685), Caenorhabditis elegans Sir-2.1 (GenBank login numbering NP_501912) and human SIRT1 (GenBank login numbering NM_012238 and NP_036370 (or AF083106)) and SIRT2 (GenBank login numbering NM_012237, NM_030593, NP_036369, NP_085096 and AF083107) protein.Other family members comprise four kinds and are called extra yeast class-Sir2 gene HST1, HST2, HST3 and the HST4 of " HST gene " (homologue of Sir2), and five kinds of other people class homologue hSIRT3, hSIRT4, hSIRT5, hSIRT6 and hSIRT7 (people (1999) BBRC 260:273 such as Blachman people such as (Brachmann) (1995) Genes Dev.9:2888 and Fu Ruiyi).Preferred plucked instrument soil because of be compared to SIRT2, and those of the total more similaritys of SIRT1 (being hSIRT1) and/or Sir2, for example have at least one part be present in SIRT1 and be not present in SIRT2 the N-end sequence those plucked instrument soil because of, what for example SIRT3 had.

" SIRT1 protein " means the member of plucked instrument soil because of the sir2 family of deacetylase.In a specific embodiments, SIRT1 protein comprises yeast Sir2 (GenBank login numbering P53685), Caenorhabditis elegans Sir-2.1 (GenBank login numbering NP_501912), human SIRT1 (GenBank login numbering NM_012238 or NP_036370 (or AF083106)) and human SIRT2 (GenBank login numbering NM_012237, NM_030593, NP_036369, NP_085096 or AF083107) protein, and coordinator and fragment.In another specific embodiments, SIRT1 protein comprises that those comprise one section and are shown in the polypeptide of sequence that the aminoacid sequence of GenBank login numbering NP_036370, NP_501912, NP_085096, NP_036369 or P53685 is formed by (or in fact by).SIRT1 protein comprises that those comprise total length or a part of aminoacid sequence that is shown in GenBank login numbering NP_036370, NP_501912, NP_085096, NP_036369 or P53685; Be shown in GenBank login numbering NP_036370, NP_501912, NP_085096, NP_036369 or P53685 and have 1 to about 2,3,5,7,10,15,20,30,50,75 or the aminoacid sequence that replaces of more conservative amino acid; Number the polypeptide that NP_036370, NP_501912, NP_085096, NP_036369 or P53685 have the aminoacid sequence of at least 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98% or 99% identity with the GenBank login, and functional fragment.Polypeptide of the present invention also comprises homologue (lineal homology and collateral line homology), variant or the fragment of GenBank login numbering NP_036370, NP_501912, NP_085096, NP_036369 or P53685.

" SIRT3 protein " means the member of plucked instrument soil because of deacetylation zymoprotein family, and/or refers to the proteinic homologue of SIRT1.In a specific embodiments, SIRT3 protein comprises human SIRT3 (GenBank login numbering AAH01042, NP_036371 or NP_001017524) and mouse SIRT3 (GenBank login numbering NP_071878) protein, and coordinator and fragment.In another specific embodiments, SIRT3 protein comprises that those comprise one section and are shown in the polypeptide of sequence that the aminoacid sequence of GenBank login numbering AAH01042, NP_036371, NP_001017524 or NP_071878 is formed by (or in fact by).SIRT3 protein comprises that those comprise total length or a part of aminoacid sequence that is shown in GenBank login numbering AAH01042, NP_036371, NP_001017524 or NP_071878; Be shown in GenBank login numbering AAH01042, NP_036371, NP_001017524 or NP_071878 and have 1 to about 2,3,5,7,10,15,20,30,50,75 or the aminoacid sequence that replaces of more conservative amino acid; Number the polypeptide that AAH01042, NP_036371, NP_001017524 or NP_071878 have the aminoacid sequence of at least 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98% or 99% identity with the GenBank login, and functional fragment.Polypeptide of the present invention also comprises homologue (lineal homology and collateral line homology), variant or the fragment of GenBank login numbering AAH01042, NP_036371, NP_001017524 or NP_071878.In another specific embodiments, SIRT3 protein comprises the fragment that produces with mitochondrial matrix processing peptidase (MPP) and/or plastosome intermediate processing peptidase (MIP) cracking by with SIRT3 protein.

Term " general administration ", " administration capapie ", that " peripherality administration " reaches " administration of all border district " is cognitive by this area, refer to main component, therapeutical agent or the administering mode of other materials except directly entering central nervous system, so that it can enter patient's whole body, and therefore carry out metabolism and other similar procedure.

Term " therapeutical agent " is cognitive by this area, is meant any its tool activity for biologically, on the physiology or on the pharmacology, can be in individual the chemistry part of part or systemic effect.This term also mean anyly desire to be used for to diagnose, cure, alleviate, treatment or preventing disease, or be used to promote the desirable health of animal or human's body or spirit is grown and/or the material of situation.

Term " therapeutic efficiency " is cognitive by this area, is meant the part or the general effect that are produced by the active material of tool on the pharmacology in animal (Mammals particularly, and more particularly the be human) body.Phrase " significant quantity in the treatment " means, and makes material produce the amount of certain desirable part or whole body effect can be applied under rationally the benefiting of any treatment/dangerous ratio.Significant quantity will the variation to some extent with the severity of the subject individuality of desire and disease condition, individual body weight and age, disease condition, administering mode etc. in the treatment of this type of material, and it can be determined by those of ordinary skills.For example, some composition as herein described is passable, being applied under rationally the benefiting of this type of treatment/dangerous ratio, carries out administration with the q.s that produces desired effect.

" treatment " a certain patient's condition or disease are meant, cure and improve at least a symptom of this patient's condition or disease.

Term " vision impairment " means eyesight to be weakened, and its when treating (for example operation) often only partly can recover or be irrecoverable.The vision impairment of especially severe is called " blind " or " visual loss ", and it means, and eyesight completely loses, the eyesight variation can't be improved via correcting lens greater than 20/200, or the visual field is less than 20 degree diameters (10 degree radius).

2. sirtuin modulators

In one side, the invention provides and be used for the treatment of and/or prevent many various diseases and deficiency disorder, for example comprise with the novel plucked instrument of aging or pressure diseases associated or deficiency disorder, diabetes, obesity, neurodegenerative disease, eye disease and deficiency disorder, cardiovascular disorder, coagulation of blood deficiency disorder, inflammation, cancer and/or flush etc. native because of-modulating compound.Increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound also can be used for the treatment of in the individuality disease or the deficiency disorder that can benefit because of the increase mitochondria activity, be used to promote muscle function, be used to increase muscle ATP level or be used for the treatment of or muscle tissue damage that prevention is relevant with anoxic or ischemic.Other compounds disclosed herein are applicable to pharmaceutical composition, and/or one or more method disclosed herein.

In a specific embodiments, plucked instrument of the present invention soil is represented by structural formula (I) because of-modulating compound:

Or its esters, wherein:

X ¹To X ⁴In two be selected from-CR ^*-and-N-;

X ¹To X ⁴In other two be-CR ^*-;

R ¹Be solubilizing group (solubilizing group);

R ²For optional through low carbon number alkyl, low carbon number alkoxyl group, halogen, nitrile or-CF ₃The phenyl group that replaces; Or R ²For containing N heteroatoms and second heteroatomic 5-to the 6-element heterocycle that randomly is selected from N, O or S, wherein this heterocycle is optional replaces through methyl or halogen;

R ^*Be independently selected from when occurring-H at every turn, low carbon number alkyl or halogen;

R is-H or-CH ₃

R ' is-CH ₃Or halogen; And

N is the integer of 0-4.

Typically, R is 0 for-H and n, so that the compound of tool structural formula (I) is represented by structural formula (II):

Or its esters.

It is as follows with the preferred value of (II) compound to have structural formula (I):

X ¹To X ⁴In two be selected from-CR ^*-and-N-;

X ¹To X ⁴In other two be-CR ^*-;

R ^*Be independently selected from when occurring-H at every turn, low carbon number alkyl or halogen;

R ¹Be solubilizing group; And

R ²Be selected from optional through one or more be independently selected from-CN ,-F ,-Cl and-CF ₃The phenyl group that replaces of substituting group, and work as X ¹To X ⁴Respectively be-CR ^*-time, R ²Be selected from extraly and contain N heteroatoms and second heteroatomic 5-to the 6-element heterocycle that randomly is selected from N, O or S, wherein this heterocycle is optional through methyl substituted.

In some specific embodiments, X ¹To X ⁴Be-CR ^*-.In other specific embodiments, X ¹To X ⁴One of them is-N-and all the other are-CR ^*-.In some specific embodiments, X ¹To X ⁴In two be-N-and all the other are-CR ^*-.In some specific embodiments, X ¹To X ⁴In two be-N-X ¹With X ²For-N-.In some specific embodiments, X ¹To X ⁴In two be-N-X ¹With X ⁴For-N-.In some specific embodiments, work as X ¹To X ⁴One of them is-during N-, and X ¹For-N-.In some specific embodiments, R ^*Be H.

In some specific embodiments, for example work as X ¹To X ⁴Be-CR ^*-time, R ²Be selected from phenyl, fluorophenyl, difluorophenyl, chloro-phenyl-, methylthiazol base, pyrimidyl, pyridyl and pyrazolyl.In some this type of specific embodiments, R ²Be selected from phenyl, fluorophenyl, difluorophenyl, chloro-phenyl-, 2-methylthiazol-4-base, pyridyl and pyrazol-1-yl.Preferably, R ²Be phenyl or pyridyl.

In some specific embodiments, R ¹For-CH ₂-R ³, and R ³Be selected from C for optional through one or more ₁-C ₄Alkyl, amino, halogen, methoxyl group and methoxyl group-C ₁-C ₄The nitrogen heterocyclic ring that the substituting group of-alkyl replaces.In these specific embodiments, X ¹To X ⁴And R ²Can have aforesaid arbitrary value.In some this type of specific embodiments, R ²Be phenyl, pyridyl or 3-fluorophenyl; X ²With X ³For-CR ^*-and X ¹With X ⁴Be independently selected from-CR ^*-or-N-; Or the two.

In some specific embodiments, R ¹For-CH ₂-R ³, and R ³Be selected from piperazine (piperazin)-1-base, 4-(methoxy ethyl-piperazine-1-base, 3,5-lupetazin-1-base, morpholine (morpholin)-4-base, piperidines-1-base, 4-amino piperidine-1-base, tetramethyleneimine-1-base, 3-fluoropyrrolidine-1-base ,-NH-(tetramethyleneimine-3-yl) and 1,4-phenodiazine-dicyclo [2.2.1] heptan-1-base.In these specific embodiments, X ¹To X ⁴And R ²Can have aforementioned arbitrary value, but R typically ²Be phenyl, pyridyl or 3-fluorophenyl; X ²With X ³For-CH-and X ¹With X ⁴Be independently selected from-CH-or-N-; Or the two.

In some this type of specific embodiments, R ³Be selected from 4-(methoxy ethyl)-piperazine-1-base, morpholine-4-base, piperidines-1-base and 4-amino piperidine-1-base.Work as R ³When having these values, R ²Be phenyl, 3-fluorophenyl or pyridyl typically.Again, X typically ²With X ³For-CH-and X ¹With X ⁴Be independently selected from-CH-or-N-.In special specific embodiments, X ¹With X ⁴Be independently selected from-CH-or-N-; X ²With X ³For-CH-; R ²Be phenyl, 3-fluorophenyl or pyridyl; And R ¹For-CH ₂-R ³, R wherein ³Be selected from 4-(methoxy ethyl)-piperazine-1-base, morpholine-4-base, piperidines-1-base and 4-amino piperidine-1-base.

In some specific embodiments, the plucked instrument soil that is comprised by structural formula (I) is represented by structural formula (III) because of-modulating compound:

Or its esters, wherein:

X ¹To X ³One of them is selected from-CH-and-N-;

X ¹To X ³In other two be-CH-;

R ¹Be solubilizing group;

R ²For optional through methyl, halogen or-CF ₃The phenyl group that replaces, or R ²For containing N heteroatoms and second heteroatomic 5-to the 6-element heterocycle that randomly is selected from N, O or S, wherein this heterocycle is optional replaces through methyl or halogen;

R is-H or-CH ₃

R ' is-CH ₃Or halogen; And

N is the integer of 0-4.

Typically, R is 0 for-H and n, so that the compound of tool structural formula (III) is represented by structural formula (IV):

Preferred value in tool structural formula (III) and the compound (IV) is as follows:

X ¹To X ³In one be selected from-CH-and-N-;

X ¹To X ³In other two be-CH-;

R ¹Be solubilizing group; And

R ²Be selected from phenyl or fluorophenyl, and work as X ¹To X ³Respectively be-during CH-, R ²Be selected from extraly and contain N heteroatoms and second heteroatomic 5-to the 6-element heterocycle that randomly is selected from N, O or S, wherein this heterocycle is optional through methyl substituted.

In some specific embodiments, X ¹To X ³Be-CH-.In other specific embodiments, X ¹To X ³In one be-N-and all the other are-CH-.Typically, X ¹To X ³In one be-N-X ¹For-N-.

In some specific embodiments, for example work as X ¹To X ³Be-during CH-, R ²Be selected from phenyl, fluorophenyl, methylthiazol base, pyrimidyl, pyridyl and pyrazolyl.In some this type of specific embodiments, R ²Be selected from phenyl, fluorophenyl, 2-methylthiazol-4-base, pyridyl and pyrazol-1-yl.Preferably, R ²Be phenyl or pyridyl.

In some specific embodiments, R ¹For-CH ₂-R ³, and R ³Be selected from C for optional through one or more ₁-C ₄Alkyl, amino, halogen, methoxyl group and methoxyl group-C ₁-C ₄The nitrogen heterocyclic ring that the substituting group of-alkyl replaces.In these specific embodiments, X ¹To X ³And R ²Can have aforesaid arbitrary value.In some this type of specific embodiments, R ²Be phenyl, pyridyl or 3-fluorophenyl; X ²With X ³For-CH-and X ¹For-CH-or-N-; Or the two.

In some specific embodiments, R ¹For-CH ₂-R ³, and R ³Be selected from piperazine-1-base, 4-(methoxy ethyl-piperazine-1-base, 3,5-lupetazin-1-base, morpholine-4-base, piperidines-1-base, 4-amino piperidine-1-base, tetramethyleneimine-1-base, 3-fluoropyrrolidine-1-base ,-NH-(tetramethyleneimine-3-yl) and 1,4-phenodiazine-dicyclo [2.2.1] heptan-1-base.In these specific embodiments, X ¹To X ³And R ²Can have aforesaid arbitrary value, but R typically ²Be phenyl, pyridyl or 3-fluorophenyl; X ²With X ³For-CH-and X ¹For-CH-or-N-; Or the two.

In some this type of specific embodiments, R ³Be selected from 4-(methoxy ethyl)-piperazine-1-base, morpholine-4-base, piperidines-1-base and 4-amino piperidine-1-base.Work as R ³When having these values, R ²Be phenyl, 3-fluorophenyl or pyridyl typically.Again, X typically ²With X ³For-CH-and X ¹For-CH-or-N-.In special specific embodiments, X ¹For-CH-or-N-; X ²With X ³For-CH-; R ²Be phenyl, 3-fluorophenyl or pyridyl; And R ¹For-CH ₂-R ³, R wherein ³Be selected from 4-(methoxy ethyl)-piperazine-1-base, morpholine-4-base, piperidines-1-base and 4-amino piperidine-1-base.

In another specific embodiments, plucked instrument of the present invention soil is represented by the structure formula V because of-modulating compound:

Or its esters, wherein:

Ring A is selected from:

R ¹Be solubilizing group; And

R ^#For-H or-O-CH ₃

In another specific embodiments again, plucked instrument soil of the present invention is represented by structural formula (VI) because of-modulating compound:

Or its esters, wherein:

Ring B is selected from:

R ¹Be solubilizing group.

For the preferred solubilizing group of structure formula V-(VI), with identical in the structural formula (I)-(IV) as described above.

Compound of the present invention (comprising new compound of the present invention) also can be used for method as herein described.

Plucked instrument of the present invention soil is advantageously regulated plucked instrument soil because of proteinic level and/or activity because of-modulating compound, and particularly plucked instrument soil is because of proteinic deacetylation enzymic activity.

Respectively or except aforesaid properties; some plucked instrument soil of the present invention because of-modulating compound this compound effectively regulate plucked instrument soil because of protein (for example; SIRT1 and/or SIRT3 protein) the active concentration of deacetylation under, do not have following one or more activity in fact: suppress the PI3-kinases, suppress alditol reductase enzyme (aldoreductase), suppress Tyrosylprotein kinase, Transactivation (transactivate) EGFR Tyrosylprotein kinase, coronary artery expansion or separate the spasm activity.

Alkyl is the complete saturated non-aromatic hydrocarbon of straight chain, side chain or ring-type.Typically, the straight or branched alkyl group has 1 to about 20 carbon atoms (being preferably 1 to about 10), and the cyclic alkyl group has 3 to about 10 carbon atoms (being preferably 3 to about 8).The example of straight chain and branched alkyl group comprises methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, second-butyl, the tertiary butyl, amyl group, hexyl, heptyl and octyl group.C1-C4 straight or branched alkyl group is also referred to as " low carbon number alkyl " group.

Aromatic group (aryl) comprises carbocyclic ring class aromatic group for example phenyl, naphthyl and anthryl, reaches heteroaryl groups for example imidazolyl, thienyl, furyl, pyridyl, pyrimidyl, pyranyl, pyrazolyl, pyrryl, pyrazinyl, thiazolyl, oxazolyl and tetrazyl.

Aromatic group also comprises fused polycycle aromatics ring system, and wherein carbocyclic ring class aromatic ring or heteroaryl ring are through being fused to one or more other heteroaryl rings.Example comprises benzothienyl, benzofuryl, indyl, quinolyl, benzothiazolyl, benzoxazolyl, benzimidazolyl-, quinolyl, isoquinolyl and pseudoindoyl.

Be positioned at the suitable substituting group on the alkyl or aryl group (carbocyclic ring class and heteroaryl), one or more that can not disturb in fact that the compound that discloses can have be the characteristic that discloses herein.When having a certain substituent compound compared to not having this substituent compound, its characteristic scale reduces to surpass at about 50% o'clock, then this substituting group characteristic of interfering compound in fact.Suitable substituent example comprises-OH, halogen (Br ,-Cl ,-I with-F) ,-OR ^a,-O-COR ^a,-COR ^a,-C (O) R ^a,-CN ,-NO ²,-COOH ,-COOR ^a,-OCO ₂R ^a,-C (O) NR ^aR ^b,-OC (O) NR ^aR ^b,-SO ₃H ,-NH ₂,-NHR ^a,-N (R ^aR ^b) ,-COOR ^a,-CHO ,-CONH ₂,-CONHR ^a,-CON (R ^aR ^b) ,-NHCOR ^a,-NRCOR ^a,-NHCONH ₂,-NHCONR ^aH ,-NHCON (R ^aR ^b) ,-NR ^cCONH ₂,-NR ^cCONR ^aH ,-NR ^cCON (R ^aR ^b) ,-C (=NH)-NH ₂,-C (=NH)-NHR ^a,-C (=NH)-N (R ^aR ^b) ,-C (=NR ^c)-NH ₂,-C (=NR ^c)-NHR ^a,-C (=NR ^c)-N (R ^aR ^b) ,-NH-C (=NH)-NH ₂,-NH-C (=NH)-NHR ^a,-NH-C (=NH)-N (R ^aR ^b) ,-NH-C (=NR ^c)-NH ₂,-NH-C (=NR ^c)-NHR ^a,-NH-C (=NR ^c)-N (R ^aR ^b) ,-NR ^dH-C (=NH)-NH ₂,-NR ^d-C (=NH)-NHR ^a,-NR ^d-C (=NH)-N (R ^aR ^b) ,-NR ^d-C (=NR ^c)-NH ₂,-NR ^d-C (=NR ^c)-NHR ^a,-NR ^d-C (=NR ^c)-N (R ^aR ^b) ,-NHNH ₂,-NHNHR ^a,-NHR ^aR ^b,-SO ₂NH ₂,-SO ₂NHR ^a,-SO ₂NR ^aR ^b,-CH=CHR ^a,-CH=CR ^aR ^b,-CR ^c=CR ^aR ^b, CR ^c=CHR ^a,-CR ^c=CR ^aR ^b,-CCR ^a,-SH ,-SO _kR ^a(k is 0,1 or 2) ,-S (O) _kOR ^a(k is 0,1 or 2) and-NH-C (=NH)-NH ₂R ^a-R ^dAll, be selected from aliphatic series, phenmethyl or aromatic group, preferred alkyl, phenmethyl or aromatic yl group independently for the optional group that replaces.Be positioned at R ^a-R ^dOn optional substituting group be selected from NH ₂, NH (C _1-4Aliphatic series), N (C _1-4Aliphatic series) ₂, halogen, C _1-4Aliphatic series, OH, O (C _1-4Aliphatic series), NO ₂, CN, CO ₂H, CO ₂(C _1-4Aliphatic series), O (halogen C _1-4Aliphatic) or halogen C _1-4Aliphatic series, wherein each aforesaid C _1-4Aliphatic group is unsubstituted.In addition ,-NR ^aR ^b, together, also can form the non-aromatic heterocyclic group that is substituted or is unsubstituted.Aliphatic series that is substituted or the aromatic yl group that is substituted can have more than one substituting group.

The representative substituting group that is positioned on the aryl rings is selected from solubilizing group, halogen;-R ^o-OR ^o-SR ^o1, the 2-methylene-dioxy; Ethylenedioxy; Optional through R ^oThe phenyl (Ph) that replaces; Optional through R ^oReplace-O (Ph);-(CH ₂) _1-2(Ph), optional through R ^oReplace;-CH=CH (Ph), optional through R ^oReplace;-NO ₂-CN;-N (R ^o) ₂-C (O) C (O) R ^o-C (O) CH ₂C (O) R ^o-CO ₂R ^o-C (O) R ^o-S (O) ₂R ^o-SO ₂N (R ^o) ₂-S (O) R ^o-NR ^oSO ₂N (R ^o) ₂-NR ^oSO ₂R ^o-C (=S) N (R ^o) ₂Or-C (=NH)-N (R ^o) ₂Or R wherein ^oBe independently selected from hydrogen, the optional C that is substituted when occurring at every turn _1-6Aliphatic series, 5-6 person's heteroaryl of being unsubstituted or heterocycle, phenyl ,-O (Ph) or-CH ₂(Ph), perhaps (although definition as described above) R ^oIndependent twice o'clock (being positioned on identical substituting group or the different substituents) and each R of occurring ^oThe atom of group institute bond forms together has 0-3 3-8-person's cycloalkyl, heterocyclic radical, aryl or heteroaryl ring that independently is selected from nitrogen, oxygen or sulfur heteroatom.Be positioned at R ^oAliphatic group on optional substituting group be selected from NH ₂, NH (C _1-4Aliphatic series), N (C _1-4Aliphatic series) ₂, halogen, C _1-4Aliphatic series, OH, O (C _1-4Aliphatic series), NO ₂, CN, CO ₂H, CO ₂(C _1-4Aliphatic series), O (halogen C _1-4Aliphatic) or halogen C _1-4Aliphatic series, wherein each aforesaid R ^oC _1-4Aliphatic group is unsubstituted.

The substituting group of the present invention's imagination and the combination of variant are that meeting forms those of stable compound.As being used for this paper, term " stable " means the stability that compound has is enough to make its manufacturing, and can make the integrity of this compound keep one section, can be used for the enough time of the purpose that describes in detail herein.

As be used for this paper, " solubilizing group " is for having the hydrophilic characteristics part that is enough to promote or increases water solubility that the compound that comprises this group is wherein arranged (when when not comprising the similar compound of this group).Hydrophilic characteristics can realize by any way, for example by comprise can be under in order to the condition that forms electrically charged part (for example, carboxylic acid, sulfonic acid, phosphoric acid, amine etc.) Ionized functional group; It comprises the group (for example quaternary ammonium group) of permanent electric charge; And/or heteroatoms or heteroatom group (for example O, S, N, NH, N-(CH ₂) _y-R ^a, N-(CH ₂) _y-C (O) R ^a, N-(CH ₂) _y-C (O) OR ^a, N-(CH ₂) _y-S (O) ₂R ^a-, N-(CH ₂) _y-S (O) ₂OR ^a, N-(CH ₂) _y-C (O) NR ^aR ^aDeng, R wherein ^aBe selected from hydrogen, low carbon number alkyl, low carbon number cycloalkyl, (C6-C14) aryl, phenyl, naphthyl, (C7-C20) arylalkyl and phenmethyl, wherein R ^aBe substituted for optional; And y is the integer between 0 to 6), the optional heterocyclic group that replaces (for example-(CH ₂) _n-R ^b,-(CH ₂) _n-C (O)-R ^b,-(CH ₂) _n-O-(CH ₂) _n-R ^b, R wherein ^bBe selected from the non-aryl-heterocyclic that the optional saturated monocyclic heterocycles that is substituted, the optional saturated bicyclic annelated heterocycles that is substituted, the optional saturated bicyclic spiroheterocyclic that is substituted, the optional heteroaryl that is substituted and the optional part that is substituted are substituted; And n is the integer between 0 to 2).Should be appreciated that, be present in R ^aOr R ^bOn substituting group do not need to promote or increase water solubility than its relative part that is unsubstituted that is contained in the scope of the invention.Needed is that this type of substituting group can significantly not reversed by the R that is unsubstituted ^aOr R ^bThe partly increase of the water solubility that is brought.

In a specific embodiments, the water solubility increase that solubilizing group makes the respective compound that lacks this solubilizing group at least 5-doubly, preferably at least 10-doubly, more preferably at least 20-doubly and most preferably 50-is doubly at least.

In a preferred specific embodiments, solubilizing group is the part with following formula :-(CH ₂) _n-R ¹⁰⁰-N (R ¹⁰¹) (R ¹⁰¹), wherein:

N is selected from 0,1 or 2;

R ¹⁰⁰Be selected from key ,-C (O)-or-O (CH ₂) _nAnd

Each R ¹⁰¹Be independently selected from:

A. hydrogen;

B.C ₁-C ₄The straight or branched alkyl, wherein this alkyl is randomly through halogen, CN, OH, O-(C ₁-C ₄The straight or branched alkyl), N (R ₁') (R ₁') or=the O replacement;

F. two R ¹⁰¹Partly common nitrogen-atoms with its bond forms ring structure

G. two R ¹⁰¹Partly common nitrogen-atoms with its bond forms the 5-person's heteroaryl ring that contains 1 to 3 extra N atom, and wherein this heteroaryl ring is randomly through R ₁' replace;

Wherein:

Each Z is independently selected from-O-,-S-,-NR ₁'-or-C (R ⁵⁰) (R ⁵⁰)-, be wherein:

Z ₂₀, Z ₂₁, Z ₂₂And Z ₂₃In at least three be-C (R ⁵⁰) (R ⁵⁰)-;

Z ₂₄, Z ₂₅, Z ₂₆, Z ₂₇And Z ₂₈In at least three be-C (R ⁵⁰) (R ⁵⁰)-;

Z ₃₀, Z ₃₁, Z ₃₂And Z ₃₃In at least four be-C (R ⁵⁰) (R ⁵⁰)-; And

Z ₃₄, Z ₃₅, Z ₃₆, Z ₃₇And Z ₃₈In at least four be-C (R ⁵⁰) (R ⁵⁰)-

Each R ₁' be independently selected from hydrogen or C ₁-C ₃The straight or branched alkyl, randomly through one or more be independently selected from halogen ,-CN ,-OH ,-OCH ₃,-NH ₂,-NH (CH ₃) ,-N (CH ₃) ₂Or=substituting group of O replaces;

Each R ⁵⁰Be independently selected from R ₁', halogen, CN, OH, O-(C ₁-C ₄The straight or branched alkyl), N (R ₁') (R ₁') ,=CR ₁', SR ₁' ,=NR ₁' ,=NOR ₁' or=O;

Any two suitable non-annularity R ⁵⁰Randomly direct, or via C ₁To C ₂Alkylidene group (alkylene), alkenylene (alkenylene) or alkane two subunit bridges (alkanediylidene) are bond each other, and produces bicyclic condensed or volution; And

Arbitrary

Ring structure is randomly through benzo-fused or be fused to bicyclic heteroaryl and produce dicyclo.

For asking clear, term " C ₁To C ₂Alkylidene group, alkenylene or alkane two subunit bridges (alkanediylidenebridge) " mean multivalence structure-CH ₂-,-CH ₂-CH ₂-,-CH=,=CH-,-CH=CH-or=CH-CH=.Two of bond R each other randomly ⁵⁰Partly, can be positioned on identical carbon atoms or the different carbon atom.The former produces the spiral shell dicyclo, and the latter produces condensed-bicyclic.To it will be evident to one of ordinary skill in the art that as two R ⁵⁰Bond and when forming ring (directly or via aforementioned wherein a kind of bridging) each other will lose and is positioned at each R ⁵⁰On one or more terminal hydrogen atom.So, can be used for forming " the suitable acyclic R of ring ⁵⁰" partly, for comprising the non-annularity R of at least one terminal hydrogen atom ⁵⁰

In another preferred specific embodiments, solubilizing group is the part with following formula :-(CH ₂) _n-O-R ¹⁰¹, wherein n and R ¹⁰¹As defined above.

In another preferred specific embodiments, solubilizing group is the part with following formula :-(CH ₂) _n-C (O)-R ₁', wherein n and R ₁' as defined above.

In another preferred specific embodiments, solubilizing group is selected from-(CH ₂) _n-R ¹⁰², wherein n is 0,1 or 2, is preferably 2; And R ¹⁰²Be selected from

R wherein ₁' as defined above.

In some special specific embodiments; solubilizing group is selected from 2-dimethyl aminoethyl formamyl; piperazine-1-base carbonyl; the piperazinyl methyl; dimethylaminomethyl; 4-methylpiperazine-1-ylmethyl; 4-amino piperidine-1-ylmethyl; 4-fluorine piperidines-1-ylmethyl; the morpholinyl methyl; tetramethyleneimine-1-ylmethyl; 2-oxygen-4-phenmethyl piperazine-1-ylmethyl; 4-phenmethyl piperazine-1-ylmethyl; 3-oxygen piperazine-1-ylmethyl; piperidines-1-ylmethyl; piperazine-1-base ethyl; 2; 3-dioxy propyl group amino methyl; thiazolidine-3-ylmethyl; 4-ethanoyl piperazine-1-ylmethyl; 4-ethanoyl piperazine-1-base; morpholinyl; 3; 3-difluoro azetidine-1-ylmethyl; 2H-tetrazolium-5-ylmethyl; thiomorpholine-4-ylmethyl; 1-oxygen thiomorpholine-4-ylmethyl; 1; 1-dioxy thiomorpholine-4-ylmethyl; 1H-imidazoles-1-ylmethyl; 3; 5-lupetazin-1-ylmethyl; 4-hydroxy piperidine-1-ylmethyl; N-methyl (1-ethanoyl piperidin-4-yl)-amino methyl; N-methyl quinuclidine ring-3-base-amino methyl; 1H-1; 2,4-triazol-1-yl methyl; 1-methyl piperidine-3-base-oxygen ylmethyl or 4-fluorine piperidines-1-base.

To a certain extent, be not included in aforementioned listed any definition, term " solubilizing group " also comprise disclose and be affixed to 1-cyclopropyl-6-fluoro-1, the part of the 7-position of 4-dihydro-4-oxygen quinoline-3-carboxylic acid (Ciprofloxacin (ciprofloxacin)) and derivative thereof, as be disclosed in the open WO2005/026165 of PCT, WO 2005/049602 and WO 2005/033108, reach European patent open EP0343524, EP 0688772, EP 0153163, EP 0159174; And " water-solubilizing group " described in the U.S. Patent Publication 2006/0035891.All include the content that these patent disclosures disclosed in this paper with way of reference.

Compound disclosed herein also comprises through part and complete deuterated variant.In some specific embodiments, have one or more D atom for carrying out dynamics research.The position that those of ordinary skills can select this type of D atom to exist.

The present invention also comprises the salt of plucked instrument described herein soil because of-modulating compound, particularly pharmaceutically acceptable salt.Have abundant acidity, the abundant functional group's of alkalescence or these two property The compounds of this invention, can with many inorganic base, and inorganic and organic acid in any form salt.Perhaps, intrinsic charged compound (compound that for example has quaternary nitrogen) can form salt with suitable gegenion (for example, halogenide such as bromide, muriate or fluorochemical, particularly bromide).

Compound and its esters described herein also comprise, hydrate of compound and its esters (for example, semihydrate, monohydrate, dihydrate, trihydrate, tetrahydrate) and solvate.Be applicable to the solvent of preparation solvate and hydrate, generally can select for use by those of ordinary skills.

Compound and its esters can amorphous, or crystallization (comprising altogether-crystallization and polymorph) form exists.

The acids that generally is used to form acid salt is an inorganic acids, for example classes such as spirit of salt, Hydrogen bromide, hydroiodic acid HI, sulfuric acid, phosphoric acid, and organic acid are classes such as p-toluenesulphonic acids, methylsulfonic acid, oxalic acid, p-bromophenyl-sulfonic acid, carbonic acid, succsinic acid, citric acid, phenylformic acid, acetic acid for example.The example of this type of salt comprises vitriol, pyrosulphate, bisul-phate, sulphite, bisul-phite, phosphoric acid salt, single hydrogen orthophosphate, dihydrogen orthophosphate, metaphosphate, pyrophosphate salt, muriate, bromide, iodide, acetate, propionic salt, caprate, octylate, acrylate, formate, isobutyrate, hexanoate, enanthate, propiolate, oxalate, malonate, succinate, suberate, sebacate, fumarate, maleic acid salt, butine-1, the 4-diacid salt, hexin-1, the 6-diacid salt, benzoate, chloro benzoate, tolyl acid salt, dinitro-benzoate, hydroxy benzoate, methoxybenzoic acid salt, phthalate, sulfonate, xylenesulfonate, phenylacetic acid salt, phenylpropionic acid salt, phenylbutyric acid salt, Citrate trianion, lactic acid salt, gamma hydroxybutyrate, glycollate, tartrate, mesylate, propanesulfonic acid salt, naphthalene-1-sulfonate, naphthalene-2-sulfonic acid salt, classes such as mandelate.

Base addition salt comprises derived from inorganic base, for example those salt such as ammonium or basic metal or alkaline earth metal hydroxides, carbonate, supercarbonate.This type of can be used for preparing the bases of salt of the present invention so comprises sodium hydroxide, potassium hydroxide, ammonium hydroxide, salt of wormwood etc.

According to another specific embodiments, the invention provides the method for aforementioned defined plucked instrument soil of making because of-modulating compound.These compounds can use known technology to synthesize and obtain.Advantageously, these compounds can obtain by the starting material of easy acquisition is synthetic easily.

A kind of method for preparing The compounds of this invention comprises the compound with the tool following formula:

Wherein X is leavings group (for example halogen such as Cl), with ring-occlusive agent, and reagent react and form following compounds for example:

This compounds represented ground is carried out chlorination or bromination (for example, with N-bromosuccinimide), and forms following compounds:

Wherein Hal represents halogen, also can use other leavings groups certainly.Then with this compound and optional nitrogen heterocyclic ring (for example, optional R through protection through protection ³Group) reaction, and form following compounds:

Wherein this nitrogen heterocyclic ring randomly is substituted, and randomly comprises one or more extra heteroatoms.With this compound and suitable reductive agent (for example iron powder) reaction, and form following compounds:

Then with this compound and R ²The pyridine carboxylic acid of-replacement, or R ²-substituted benzoyl acid-respons, and as required it is gone protection and the formation The compounds of this invention.

Can be used for synthetic plucked instrument soil described herein is well known in the art because of the synthetic chemistry transformation and the method for-modulating compound, and comprise, for example those are described in R. La Luoke (Larock), comprehensive organic transformation effect (Comprehensive Organic Transformations) (1989); T.W. Green can (Greene) and P.G.M. 5 this (Wuts), the protecting group of organic synthesis (Protective Groups inOrganic Synthesis), 2d.Ed. (1991); L. take plucked instrument (Fieser) and M. expense plucked instrument, be used for the expense plucked instrument and expense Se Shi reagent (Fieser and Fieser ' s Reagents for OrganicSynthesis) (1994) of organic synthesis; And L. Pai Kuite (Paquette), write effect and method in the encyclopedia of organic synthesis reagent (Encyclopedia of Reagents for Organic Synthesis) (1995).

In an exemplary specific embodiments, plucked instrument soil because of-modulating compound may be across the cytoplasmic membrane of cell.For example, compound can have the cell-penetrability at least about 20%, 50%, 75%, 80%, 90% or 95%.

Plucked instrument as herein described soil also can have one or more following feature because of-modulating compound: compound in fact pair cell or individual be nontoxicity; Compound can be tool 2000amu or following, 1000amu or following organic molecule or small molecules; Compound can have the transformation period that is at least about 30 days, 60 days, 120 days, 6 months or 1 year under normal atmospheric condition; Compound can have the transformation period that is at least about 30 days, 60 days, 120 days, 6 months or 1 year in solution; Plucked instrument soil can be stablized at least about 50%, 2 times, 5 times, 10 times, 30 times, 50 times or 100 times than trans-resveratrol (resveratrol) in solution because of-modulating compound; Plucked instrument soil can promote the deacetylation of DNA reparative factor Ku70 to turn usefulness into because of-modulating compound; Plucked instrument soil can promote the deacetylation of RelA/p65 to turn usefulness into because of-modulating compound; Compound can increase general switching rate, and the enhancing cell brings out apoptotic susceptibility to TNF-.

In some specific embodiments; plucked instrument soil because of-modulating compound (for example in the body) effectively regulate plucked instrument native because of the active concentration of deacetylase under, do not have the essence ability of any inhibition I class histone deacetylase (HDACs), II class HDAC or HDACs I and II.For example, in preferred specific embodiments, plucked instrument soil is plucked instrument soil because of-reactivity compound because of-modulating compound, and selects those to have activating plucked instrument soil because of the active EC of deacetylase ₅₀Value is for the EC that suppresses HDAC I and/or HDAC II ₅₀Few at least 5 times of value, and even preferred few at least 10 times, 100 times or even 1000 times plucked instrument soil because of-reactivity compound.Be used to analyze HDAC I and/or the active method of HDAC II is known in the art, and the test kit (kit) that carries out this alanysis can be buied in commercial.Referring to for example, BioVision limited-liability company (Mountain View, CA; Network address biovision.Com) and Rob Thomas science (Thomas Scientific) (Swedesboro, NJ; Network address tomassci.Com).

In some specific embodiments, plucked instrument soil does not have the essence ability of any adjusting plucked instrument soil because of homologue because of-modulating compound.In one embodiment; human plucked instrument soil is because of proteinic activator; (for example in vivo) effectively activate human plucked instrument soil because of the active concentration of deacetylase under; may not have any activation and derive from lower eukaryotes, particularly the plucked instrument soil of yeast or human pathogenic bacteria is because of proteinic essence ability.For example, plucked instrument soil because of-the reactivity compound can be selected to have for the human plucked instrument of activation native because of (for example SIRT1 and/or SIRT3) the active EC of deacetylase ₅₀Value is for the EC of activation yeast plucked instrument soil because of (for example Sir2 (as Candida, yeast saccharomyces cerevisiae etc.)) ₅₀Few at least 5 times of value, and even preferred few at least 10 times, 100 times or even those compounds of 1000 times.In another embodiment; the plucked instrument soil that derives from lower eukaryotes (particularly yeast or human pathogenic bacteria) is because of proteinic inhibitor; the plucked instrument soil that effectively suppresses to derive from lower eukaryotes in (for example in vivo) because of the active concentration of proteinic deacetylase under, do not have any inhibition and derive from human plucked instrument soil because of proteinic essence ability.For example, plucked instrument soil because of-the inhibition compound can be selected to have for suppressing human plucked instrument native because of (for example SIRT1 and/or SIRT3) the active IC of deacetylase ₅₀Value is for suppressing the IC of yeast plucked instrument soil because of (for example Sir2 (as Candida, yeast saccharomyces cerevisiae etc.)) ₅₀Few at least 5 times of value, and even preferred few at least 10 times, 100 times or even those compounds of 1000 times.

In some specific embodiments, plucked instrument soil can have one or more human plucked instrument soil of adjusting because of homologue, such as the ability of (for example) one or more human SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6 or SIRT7 because of-modulating compound.In one embodiment, plucked instrument soil has adjusting SIRT1 and the proteinic ability of SIRT3 because of-modulating compound.

In other specific embodiments; the SIRT1 conditioning agent is effectively regulated under the active concentration of deacetylase of human SIRT1 in (for example in vivo); do not have other plucked instrument soil of adjusting because of protein homologs, such as the essence ability of (for example) one or more human SIRT2, SIRT3, SIRT4, SIRT5, SIRT6 or SIRT7.For example, plucked instrument soil can be selected to have for the active ED of the human SIRT1 deacetylase of adjusting because of-modulating compound ₅₀Value is for the ED that regulates one or more human SIRT2, SIRT3, SIRT3, SIRT4, SIRT5, SIRT6 or SIRT7 ₅₀Few at least 5 times of value, and even preferred few at least 10 times, 100 times or even those compounds of 1000 times.In one embodiment, the SIRT1 conditioning agent does not have the proteinic essence ability of any adjusting SIRT3.

In other specific embodiments; the SIRT3 conditioning agent is effectively regulated under the active concentration of deacetylase of human SIRT3 in (for example in vivo); do not have other plucked instrument soil of adjusting because of protein homologs, such as the essence ability of (for example) one or more human SIRT1, SIRT2, SIRT4, SIRT5, SIRT6 or SIRT7.For example, plucked instrument soil can be selected to have for the active ED of the human SIRT3 deacetylase of adjusting because of-modulating compound ₅₀Value is for the ED that regulates one or more human SIRT1, SIRT2, SIRT4, SIRT5, SIRT6 or SIRT7 ₅₀Few at least 5 times of value, and even preferred few at least 10 times, 100 times or even those compounds of 1000 times.In a specific embodiments, the SIRT3 conditioning agent does not have the proteinic essence ability of any adjusting SIRT1.

In some specific embodiments, plucked instrument soil is about 10 because of-modulating compound can have for plucked instrument soil because of combination of proteins avidity ^-9M, 10 ^-10M, 10 ^-11M, 10 ^-12Or below.Plucked instrument soil because of-modulating compound can reduce (activator) or increase (inhibitor) plucked instrument soil reaches at least about 2,3,4,5,10,20,30,50 or 100 times because of the apparent Km value of protein for its substrate or NAD+ (or other cofactors).In some specific embodiments, the Km value is to use mass spectroscopy as herein described to measure and obtains.Preferred reactivity compound reduces plucked instrument soil because of the Km value for its substrate or cofactor, to under similar concentration, causing more by trans-resveratrol, or reduce plucked instrument soil because of Km value for its substrate or cofactor, make it similar in appearance to the degree that under low concentration, is caused by trans-resveratrol.Plucked instrument soil because of-modulating compound can increase plucked instrument soil because of proteinic Vmax value at least about 2,3,4,5,10,20,30,50 or 100 times.Plucked instrument soil because of-modulating compound can have for adjusting SIRT1 and/or the active ED of the proteinic deacetylase of SIRT3 ₅₀Value is less than about 10nM for being less than about 1nM, is less than about 100nM, is less than about 1 μ M, is less than about 10 μ M, is less than about 100 μ M, or from about 1-10nM, from about 10-100nM, from about 0.1-1 μ M, from about 1-10 μ M or from about 10-100 μ M.Plucked instrument soil because of-modulating compound can regulate SIRT1 and/or the proteinic deacetylation enzymic activity of SIRT3 reaches at least about 5,10,20,30,50 or 100 times, is by measuring in cell analysis or the analysis (cell based assay) based on cell.Plucked instrument soil induces plucked instrument soil because of proteinic deacetylation enzymic activity because of-reactivity compound can impel, with respect to the trans-resveratrol of same concentrations greatly at least about 10%, 30%, 50%, 80%, 2 times, 5 times, 10 times, 50 times or 100 times.Plucked instrument soil can have the ED for adjusting SIRT5 because of-modulating compound ₅₀Value is for regulating SIRT1 and/or the proteinic ED of SIRT3 ₅₀Value is greatly at least about 10 times, 20 times, 30 times, 50 times.

3. exemplary purposes

In some aspects, the invention provides and be used to regulate plucked instrument soil because of proteinic level and/or active method, and using method.

In some specific embodiments, the invention provides the method for plucked instrument soil of using because of-modulating compound, wherein plucked instrument soil activates plucked instrument soil because of protein, for example increases plucked instrument soil because of proteinic level and/or activity because of-modulating compound.Increase plucked instrument soil and can be used for various treatments application because of-modulating compound because of proteinic level and/or active plucked instrument soil, comprise that (for example) increases cell survival, and treat and/or prevent many various diseases and deficiency disorder, comprise (for example) and aging or pressure diseases associated or deficiency disorder, diabetes, obesity, neurodegenerative disease, cardiovascular disorder, coagulation of blood deficiency disorder, inflammation, cancer and/or flush etc.This method comprises the plucked instrument of significant quantity in pharmacy soil because of-modulating compound, and for example plucked instrument soil gives the individuality of needs because of-reactivity compound administration.

Though the applicant is not intended to be subject to theory, believe activator of the present invention can plucked instrument soil because of the same area in the protein (for example, activity site or influence the position of the Km or the Vmax of this activity site) and plucked instrument soil because of interacting.Can believe that this is why the plucked instrument soil of some kind can have the substantial structure similarity because of activator and inhibitor a reason.

In some specific embodiments, can adopt described plucked instrument soil because of-modulating compound separately herein, or make up with other compounds.In one embodiment, can with contain two or multiple plucked instrument soil because of the mixture of-modulating compound, the individuality that needs it is given in administration.In another embodiment, increase plucked instrument soil and can carry out administration with one or more following compounds because of-modulating compound: trans-resveratrol, butein (butein), fisetin (fisetin), skin China fir alcohol (piceatannol) or Quercetin (quercetin) in vain because of proteinic level and/or active plucked instrument soil.In an exemplary specific embodiments, can because of making up ,-modulating compound and niacin (nicotinic acid) carry out administration because of proteinic level and/or active plucked instrument soil with increasing plucked instrument soil.In another specific embodiments, increase plucked instrument soil and can carry out administration because of proteinic level and/or active plucked instrument soil with one or more following compounds because of-modulating compound: niacinamide (NAM), shura be (suranim) rather; NF023 (a kind of G-protein antagonist); NF279 (a kind of purinergic receptor antagonists); Tuo Luosuo (Trolox) (6-hydroxyl-2,5,7,8, tetramethyl-benzo dihydropyrane-2-carboxylic acid); (-)-epigallocatechin (epigallocatechin) (hydroxyl be positioned at position 3,5,7,3 ', 4 ', 5 '); (-)-epigallocatechin gallic acid ester (hydroxyl be positioned at position 5,7,3 ', 4 ', 5 ', and gallic acid ester is positioned at 3); The chlorination Cyanidin (chlorination 3,5,7,3 ', 4 '-penta hydroxy group 2-phenyl-1-chroman); Delphinidin chloride (chlorination 3,5,7,3 ', 4 ', 5 '-hexahydroxy-2-phenyl-1-chroman); Myricetin (Myricetin; 3,5,7,3 ', 4 ', 5 '-quercetagetin); 3,7,3 ', 4 ', 5 '-pentahydroxyflavone; Gossypetin (3,5,7,8,3 ', 4 '-quercetagetin), Se Tingnuo (sirtinol); And Si Tuomixin (splitomicin).In another specific embodiments, plucked instrument soil can be used for the treatment of with one or more because of-modulating compound or prevent various diseases, comprises (for example) cancer, diabetes, neurodegenerative disease, cardiovascular disorder, coagulation of blood, inflammation, flush, obesity, wears out, therapeutical agent such as pressure carries out administration.In various specific embodiments, it comprises the native pharmaceutical composition because of-modulating compound and one or more therapeutical agent (for example, one or more is in therapeutical agent described herein) of one or more plucked instrument because of the combination treatment of-modulating compound can refer to (1) to comprise plucked instrument soil; And (2) one or more plucked instrument soil is because of the co-administered of-modulating compound and one or more therapeutical agent, wherein plucked instrument soil because of-modulating compound and therapeutical agent still without allocate in same composition (but can be present in identical test kit (kit) or pack, for example blister pack or other multicells are packed; Can be by being connected of separating voluntarily of user, the container (for example tinfoil paper pouch) of sealing respectively; Or wherein plucked instrument soil because of-modulating compound is interior with the test kit that other treatment agent existence separates in the container).When the composite that uses separately, plucked instrument soil because of-modulating compound can with the administration of another therapeutical agent simultaneously, intermittently, interlock, before it, continue after it, or carry out administration with their combination.

In some specific embodiments, use plucked instrument soil because of-modulating compound with reduce, the method for prevention or treatment disease or deficiency disorder, also can comprise increases the native protein level because of (for example human SIRT1, SIRT2 and/or SIRT3, or its homologue) of plucked instrument.Increase protein level can by will encode plucked instrument soil because of one or more nucleic acid copy in transfered cell and reach.For example, can by will encode plucked instrument soil because of nucleic acid import in the mammalian cell, and in the increase mammalian cell plucked instrument soil because of level, for example number the nucleic acid importing of the aminoacid sequence of NP_036370 by coding being shown in the GenBank login, and the level of increase SIRT1, and/or the nucleic acid of the aminoacid sequence by coding being shown in GenBank login numbering AAH01042 imports, and increases the level of SIRT3.

To increase the nucleic acid of plucked instrument soil because of protein level, the native sequence because of (for example SIRT1 and/or SIRT3 protein) of codified and plucked instrument has the protein at least about 80%, 85%, 90%, 95%, 98% or 99% identity in transfered cell.For example, this proteinic nucleic acid of coding can have at least about 80%, 85%, 90%, 95%, 98% or 99% identity with coding SIRT1 (for example GenBank login numbering NM_012238) and/or the proteinic nucleic acid of SIRT3 (for example GenBank login numbering BC001042).Nucleic acid also can be (being preferable under the harsh hybridization conditions) and the nucleic acid of encoding wild type plucked instrument soil because of the nucleic acid hybridization of (for example SIRT1 and/or SIRT3 protein).Harsh hybridization conditions can comprise hybridization and carry out rinsing in 0.2 * SSC under 65 ℃.When use coding and wild-type plucked instrument soil because of the different protein of protein (for example its as wild-type plucked instrument native because of fragment) nucleic acid the time, this protein preferably has activity biologically, for example can carry out deacetylation and turn usefulness into.Only need in cell, show its at the active plucked instrument soil of tool biologically because of partly getting final product.For example, the different protein of wild-type SIRT1 with having GenBank login numbering NP_036370 preferably contains its core texture.Core texture is meant the amino acid 62-293 of GenBank login numbering NP_036370 sometimes, and its Nucleotide 237 to 932 by GenBank login numbering NM_012238 is coded, and it includes NAD combination and substrate combined function territory.The Core Feature territory of SIRT1 also can refer to the amino acid 261 to 447 of GenBank login numbering NP_036370, and its Nucleotide 834 to 1394 by GenBank login numbering NM_012238 is coded; Be meant the amino acid 242 to 493 of GenBank login numbering NP_036370, its Nucleotide 777 to 1532 by GenBank login numbering NM_012238 is coded; Or referring to that GenBank logins the amino amino acid 254 to 495 of numbering NP_036370, its Nucleotide 813 to 1538 by GenBank login numbering NM_012238 is coded.Can measure protein according to methods known in the art and whether keep biological function, for example the deacetylation ability.

In some specific embodiments, use plucked instrument soil because of-modulating compound with reduce, the method for prevention or treatment disease or deficiency disorder, also can comprise and reduce the native protein level of plucked instrument because of (for example human SIRT1, SIRT2 and/or SIRT3, or its homologue).Reducing plucked instrument soil can reach according to these methods known in the art because of protein level.For example, can in cell, express target decide plucked instrument soil because of siRNA (a kind of antisense nucleic acid) or ribozyme.Also but the plucked instrument soil of functions of use territory feminine gender for example can not carry out the mutant of deacetylationization because of mutant.For example, can use the SIRT1 mutant H363Y that is described in (for example) sieve people (2001) cell 107:137 such as (Luo).Perhaps, can use the reagent that suppresses Transcription.

Be used to regulate plucked instrument soil and also comprise because of the method for protein level, regulate coding plucked instrument soil because of the method for genetic transcription effect, the method for stabilization (stabilizing)/corresponding mRNA of stabilization removal, and other methods known in the art.

Aging/pressure

In a specific embodiments, the invention provides by cell and the present invention being increased plucked instrument soil and contact because of-modulating compound because of proteinic level and/or active plucked instrument soil, and prolong cell survival, increase the hyperplasia ability, slow down cell senescence, promote cell survival, postpone cell aging, simulation calorie limits an effect, the increase cell is to the resistance of pressure or prevent apoptotic method.In an exemplary specific embodiments, this method comprises cell and plucked instrument soil is contacted because of-reactivity compound.

Method as herein described can be used for increasing cell, particularly blastema (promptly deriving from organism, for example Ren Lei cell), can keep the time quantum of surviving in cell culture.Embryonic stem cell (Embryonic stem, ES) with multipotential cell (pluripotent cell) and by the cell of its differentiation, also can with increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound is handled, so that cell (or its filial generation) kept in culture than the time of growing.This type of cell also can be used for (for example) and is implanted in the individuality after in vitro revising (ex vivo modification).

In one embodiment, can be with the cell of desiring to be preserved for a long time, handle because of-modulating compound because of proteinic level and/or active plucked instrument soil with increasing plucked instrument soil.Cell can be present in suspension (for example hemocyte, serum, biology growth medium etc.), or is present in tissue or the organ.For example, can collect, handle because of-modulating compound because of proteinic level and/or active plucked instrument soil, thereby make hemocyte can preserve time than length with increasing plucked instrument soil from individual blood for the blood transfusion purpose.In addition, the blood that is used for court's purpose also can use and increase plucked instrument soil and do preservation because of proteinic level and/or active plucked instrument soil because of-modulating compound.Other can be treated to prolong its life-span or anti-apoptotic cells, comprises that the cell for consumption for example derives from the cell (for example meat) of non-human mammal, or vegetable cell (for example vegetables).

Also can be in growth and the vegetative period of Mammals, plant, insect or microorganism, use increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, change, slow down or accelerated development and/or process of growth with (for example).

In another embodiment, increasing plucked instrument soil can be used for because of-modulating compound because of proteinic level and/or active plucked instrument soil, processing is used for the cell for transplanting or cell therapy, comprises (for example) solid tissue graft, organ graft, cell suspending liquid, stem cell, medullary cell etc.Cell or tissue can be autotransplantation, allotransplantation, syngraft or xenotransplantation.Can be before administration/implantation with cell or tissue, reach simultaneously after administration/implantation is individual so that plucked instrument is native in administration/implantation and to handle because of-modulating compound.Can be before individual the taking-up from the supplier with cell or tissue, after getting, in vitro, or after implanting the recipient, handle from supplier's individuality.For example, can with a supplier or recipient body and function plucked instrument soil because of-modulating compound carries out general to be handled, or the subgroup (subset) that makes cell/tissue is carried out locality processing because of proteinic level and/or active plucked instrument are native because of-modulating compound with increasing plucked instrument soil.In some specific embodiments, can extraly cell or tissue be useful on the therapeutical agent that prolongs graft survival with another kind, for example immune depressor, cytokine, angiogenesis factor wait and handle.

In other specific embodiments, cell in vivo can be handled because of-modulating compound because of proteinic level and/or active plucked instrument soil with increasing plucked instrument soil, to increase its life-span or to prevent apoptosis.For example, can be by skin or epidermic cell be handled because of-modulating compound because of proteinic level and/or active plucked instrument soil with increasing plucked instrument soil, and protection skin can not wear out (for example, develop wrinkle, lose elasticity etc.).In an exemplary specific embodiments, skin is increased plucked instrument soil and contacts because of proteinic level and/or active plucked instrument soil medicine or the make-up composition because of-modulating compound with comprising.Exemplary skin puzzlement or the skin conditions that can handle according to methods described herein comprise relevant with inflammation, sunburn or weather aging or by its deficiency disorder that causes or disease.For example, the composition damage, discoid lupus erythematosus, dermatomyositis, psoriasis, skin carcinoma and the weather aging effect that can be used for prevention or treatment contact dermatitis (comprising pungency contact dermatitis and supersensitivity contact dermatitis), atopic dermatitis (being also referred to as allergic eczema), actinic keratosis, keratinization deficiency disorder (comprising eczema), epidermolysis bullosa disease (comprising pemphigus), exfoliation atopic dermatitis, seborrhea atopic dermatitis, erythema (comprising erythema multiforme and erythema nodosum), cause by Exposure to Sunlight or other light sources.In another embodiment, increasing plucked instrument soil heals promoting because of-modulating compound can be used for treating wound and/or burn because of proteinic level and/or active plucked instrument soil, comprise (for example) first degree, second degree or the thir-degree burn, and/or heat, chemistry or electric burn.Composite can be administered to skin or mucosal tissue partly.

Comprising one or more increases plucked instrument soil because of proteinic level and/or the active plucked instrument soil local composite because of-modulating compound, also can be used as preventative (for example chemoprophylaxis) composition.When being used in the chemoprophylaxis method, be particular individual occur can be visual the patient's condition before, promptly handle the skin of suffering from easily.

Can with plucked instrument soil because of-modulating compound part or general be delivered to individuality.In one embodiment, by injection, local composite (formulation) etc., plucked instrument soil is administered to the tissue or the organ of individuality partly because of-modulating compound.

In another embodiment, increase plucked instrument soil and can be used for because of-modulating compound, treatment or prevent the disease or the patient's condition of bringing out or increasing the weight of because of cell aging in the individuality because of proteinic level and/or active plucked instrument soil; In order to lower the method for individual aging rate (for example after senescing); In order to prolong the method for individual life span; Method in order to treatment or prevention and the life-span diseases associated or the patient's condition; Method in order to treatment or prevention and the ability of cell proliferation diseases associated or the patient's condition; And in order to treat or to prevent by cell injury or the dead disease that is caused or the method for the patient's condition.In some specific embodiments, this method is not to work by lowering its disease incidence rate that shortens individual life span.In some specific embodiments, this method is not to work by lowering the lethality rate that is caused because of disease (for example cancer).

In another specific embodiments again, can increase cell survival for generality, and be the purpose of protection cell counter pressure and/or antagonism apoptosis, give individuality because of proteinic level and/or active plucked instrument are native because of-modulating compound administration and will increase plucked instrument soil.Can believe,, be similar to individuality and stand hormesis (hormesis) (that is, to organism useful and can prolong the moderate pressure in its life-span) with compounds for treating individuality as herein described.

Can give individuality because of proteinic level and/or active plucked instrument soil because of-modulating compound administration with increasing plucked instrument soil, with pre-anti-aging and and aging relevant result or disease, for example apoplexy, heart disease, cardiac failure, sacroiliitis, hypertension and AIDS Alzheimer disease (Alzheimer ' s disease).Other patient's condition that can be treated comprise: for example with aging related eye deficiency disorder, for example cataract, glaucoma and macular degeneration.Also can give individuality because of proteinic level and/or active plucked instrument soil because of-modulating compound administration, protect the not dead purpose of cell and treat the disease related with thinking, for example chronic disease with necrocytosis with increasing plucked instrument soil.Exemplary disease comprises and following diseases associated: nerve cell death, neuron dysfunction or muscle cell death or dysfunction, for example Parkinson's disease, AIDS Alzheimer disease, multiple sclerosis, lateral sclerosis (amniotropic lateral sclerosis) and muscular dystrophy; AIDS; Fulminant hepatitis; With brain degeneration bonded disease, for example her Zi Feierte-cortico-striatal spinal degeneration (Creutzfeld-Jakob disease) of Crow, retinitis pigmentosa and cerebellum degeneration; Myelodysplasia (myelodysplasis) is aplastic anemia for example; The ischemia acute disease is myocardial infarction and apoplexy for example; Hepatopathy is alcoholism hepatitis, viral hepatitis type b and C type hepatitis for example; Joint disease is osteoarthritis for example; Atherosclerosis; Alopecia; The sunburn that causes by UV light; Lichen planus; Skin atrophy; Cataract; And transplant rejection.Necrocytosis also can be caused by operation, pharmacological agent, Chemical exposure or radiation exposure.

Also can give and suffer from acute illness because of-modulating compound administration because of proteinic level and/or active plucked instrument soil increasing plucked instrument soil, for example the individuality that comes to harm of organ or tissue be for example suffered from the individuality of apoplexy or myocardial infarction, or is suffered from the individuality of Spinal injury.Increase plucked instrument soil and also can be used for repairing the alcoholic liver poisoning because of-modulating compound because of proteinic level and/or active plucked instrument soil.

Cardiovascular disorder

In another embodiment, the invention provides a kind of method that treats and/or prevents cardiovascular disorder, is to give the individuality of needs because of proteinic level and/or active plucked instrument soil because of-modulating compound administration by increasing plucked instrument soil.

Can use increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of the-modulating compound treatment or the cardiovascular disorder of preventing, comprise myocardosis or myocarditis; Myocardosis, ischemic cardiomyopathy and hypertensive cerebral myocardosis that for example spontaneous myocardosis, metabolic cardiomyopathy, alcoholic cardiomyopathy, medicine cause.Also can use compound described herein and method the treatment or the prevention those, mainly be blood vessel for example aorta, coronary artery, carotid artery, arteriae cerebri, the Renal artery, iliac artery, femoral artery Ji the atherosis deficiency disorder (great vessels disease) of popliteal artery (popliteal arteries).The vascular disease that other can be treated or prevent, comprise those and platelet aggregation, retina arteriole, glomerulus arteriole, vasa nervorum (vasa nervorum), heart arteriole, and eye, kidney, heart and maincenter and the related capillary bed of peripheral neural system.Increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, also can be used for increasing the interior HDL level of individual blood plasma.

Other can comprise restenosis (for example in crown interventions back) with increasing plucked instrument soil because of proteinic level and/or the active plucked instrument soil deficiency disorder because of-modulating compound treatment, reach and high-density and the relevant deficiency disorder of low density cholesterol level unusually.

In one embodiment, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, the some that can be used as combination treatment is with another kind of cardiovascalar agent administration.In one embodiment, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, the some that can be used as combination treatment is with resisting-administration of arrhythmia medicament.In another embodiment, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, the some that can be used as combination treatment is with another kind of cardiovascalar agent administration.

Necrocytosis/cancer

Can give, accept recently maybe may will accept the individuality of doses radiation exposure or toxin because of-modulating compound administration because of proteinic level and/or active plucked instrument soil increasing plucked instrument soil.In one embodiment, the some of the dosage of accepting radiation exposure or toxin or medical program relevant as work, for example through administration as preventive measures (prophylactic measure).In another embodiment, not inadvertently accept radiation exposure or toxin exposure.In these cases, preferably after exposure, give drug compound as early as possible, become acute radiation line irradiation syndrome to suppress apoptosis and follow-up developments.

Plucked instrument soil also can be used for treating and/or preventing cancer because of-modulating compound.In some specific embodiments, increase plucked instrument soil and can be used for treating and/or preventing cancer because of-modulating compound because of proteinic level and/or active plucked instrument soil.Calorie restriction known with, reduce the incidence association of the age related disorder disease comprise cancer.So, increase plucked instrument soil because of proteinic level and/or activity, can be used for treating and/or preventing the incidence of age related disorder disease (for example cancer).Can use plucked instrument soil because of-exemplary cancer that modulating compound is treated, be following cancer: the cancer of brain and kidney; Hormone-dependence cancer comprises breast cancer, prostate cancer, carcinoma of testis and ovarian cancer; Lymphoma and leukemia.In the cancer related, the direct administration of modulating compound can be given this tumour with solid tumor.The cancer of blood cell (for example leukemia) can be treated by modulating compound is administered in the blood flow or in the marrow.Also can treat the benign cell for example wart of growing.Other diseases that can be treated comprise autoimmune disorders, and for example whole body lupus erythematosus, scleroderma and sacroiliitis wherein should be removed autoimmune cell.Also can treat and the related pernicious and optimum deficiency disorder of virus infection (for example simplexvirus, HIV, adenovirus and HTLV-1) by administration plucked instrument soil because of-modulating compound.Perhaps, can obtain cell from individuality, removing some undesirable cell (for example cancer cells), and administration is returned identical or to Different Individual again through extracorporeal treatment.

Also chemotherapeutic and the modulating compound with antitumour activity described herein for example can be brought out apoptotic compound, shorten the compound in life-span, or make cell pressure-sensitive compound co-administered.Chemotherapeutic itself can with described herein bring out apoptosis shorten the compound in life-span or make cell to pressure-sensitive plucked instrument soil because of-modulating compound, and/or be used in combination with other chemotherapeutics.Except the known chemical therapeutical agent, plucked instrument as herein described soil because of-modulating compound also can with sense-rna, RNAi, or other inhibition can cause the polynucleotide of the cellular component expression of undesirable cell proliferation to use together.

This combination comprises plucked instrument soil combination treatment, is better than the known combination treatment in the known technology, because can make the known chemical therapeutical agent than bringing into play more large effect under the low dosage because of-modulating compound and known chemical therapeutical agent.In preferred specific embodiments, for the effective dose (ED of chemotherapeutic (or combination of known chemical therapeutical agent) ₅₀), when with plucked instrument soil because of-when modulating compound is used in combination, compared to the ED of this independent chemotherapeutic ₅₀Low at least 2 times, and even preferably low 5 times, 10 times or even 25 times.Otherwise, for the therapeutic index (TI) of the combination of this type of chemotherapeutic or this type of chemotherapeutic, when with plucked instrument described herein soil because of-when modulating compound is used in combination, compare at least 2 times of the TI height of independent known chemical treatment procedure, and even more preferably high 5 times, 10 times or even 25 times.

Neuronal disease/deficiency disorder

In some aspects, increasing plucked instrument soil can be used for treatment and suffers from neurodegenerative disease, reach central nervous system (CNS), spinal cord or the wound of peripheral neural system (PNS) or the patient of mechanical injuries because of-modulating compound because of proteinic level and/or active plucked instrument soil.Neurodegenerative disease comprises human brain quality and volume typically to be reduced, and it may be because due to brain cell atrophy and/or the death, and is more far-reaching because of the person's of causing that wears out minimizing than healthy people.Neurodegenerative disease can be evolved into owing to the gradual degeneration (for example neurocyte insufficiency of function and death) in specific brain regions zone after carrying out long-term normal brain activity function gradually.Perhaps, neurodegenerative disease can have and begins fast to take place, for example those diseases that are associated with wound or toxin.Brain is degenerated and to be cut really that begin can be than Zao many years of clinical sign occurring.The example of neurodegenerative disease comprises (but being not limited to) AIDS Alzheimer disease (AD), Parkinson's disease (PD), Heng Dingdunshi disease (HD), amyotrophic lateral sclerosis (ALS; Luo Jieli Graves disease (LouGehrig ' s Disease)), the DPN of the DPN (for example from vincristine(VCR), taxol, Velcade (bortezomib)) of disperse thunder dimension corpusculum disease (diffuse Lewy body disease), tarantism-acanthocytosis, primary lateral sclerosis, eye disease (expression in the eyes is smart scorching), phase chemotherapy induced, diabetes-induced and Buddhist Reed rely Xi Shi ataxia (Friedreich ' s ataxia).Increase plucked instrument soil and can be used for treating these deficiency disorders and the described deficiency disorder of other following literary compositions because of-modulating compound because of proteinic level and/or active plucked instrument soil.

AD is a kind of CNS deficiency disorder that causes the loss of memory, abnormal behaviour, personality change and elaborative faculty decline.These forfeitures and the death of particular type brain cell, and damage relevant with binding and its support networking (for example neurogliocyte) between them.The very early time symptom comprises memory, false judgment and the personality change that forfeiture is nearest.PD be a kind of cause uncontrolled body kinematics, stiff, tremble and dyskinetic CNS deficiency disorder, dead related with the brain cell that brain is made in the zone of Dopamine HCL (dopamine).ALS (motor neurone disease) is the CNS deficiency disorder of a kind of attack motor neuron (among the CNS with brain and skeletal muscle banded component).

HD is the another kind of neurodegenerative disease that causes uncontrolled motion, intelligence forfeiture and emotional maladjustment.Tai-Sa Si disease (Tay-Sachs disease) and Sang Huofu disease (Sandhoff disease) are GM2 ganglioside wherein; the associated sugars lipid substrate that reaches Hex accumulates in the neural system, and causes acute neurodegenerative glycolipid storage diseases.

Know, apoptosis is being played an important role aspect the immune AIDS pathology.Yet HIV-1 also brings out can be with plucked instrument of the present invention soil because of-neurological disorder that modulating compound is treated.

Neurocyte forfeiture (neuronal loss) also is prion disease (prion disease), for example the prominent feature of the cat class spongiform encephalopathy (FSE) of crazy itch of BSE (mad cow disease), sheep and the goat of her Zi Feierte-cortico-striatal spinal degeneration (Creutzfeldt-Jakob) of Ren Lei Crow, ox and cat.Increase plucked instrument soil and can be used for because of-modulating compound because of proteinic level and/or active plucked instrument soil, treatment or prevention are lost by the neurocyte that these prion albumen diseases cause.

In another embodiment, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can be used for treating or preventing any disease or patient's condition that relates to aixs cylinder pathology (axonopathy).Distally aixs cylinder disease is a class by certain heavy peripheral neuropathy of causing of metabolism or toxicity entanglement of peripheral neural system (PNS) neurocyte.It is neural the most common reaction to metabolism or the disorderly entanglement of toxicity, and therefore may be by metabolic disease for example malnutrition and alcoholism of diabetes, renal failure, shortage syndrome for example, or is caused by the effect of toxin or medicine.Those are suffered from distally aixs cylinder patient and present symmetry gloves-socks template sensation-motion disorder usually.In involved area also 1 generation, deep layer tendon reflex and autonomic nervous system (ANS) afunction or reduction.

Diabetic neuropathy is the nervous disorder disease related with diabetes.May comprise the third nerve paralysis with the more common patient's condition diabetic neuropathy connection relative; Mononeuropathy; Mononeuritis multiplex; Diabetic amyotrophy; The painful polyneuropathy; Autonomic neuropathy; And ventral thoracic nerve disease.

The periphery DPN is the medical terminology that is used for peripheral neural nerve injury, may be by sacred disease, or causes because of the side effect of systemic disease.The main reason of periphery DPN comprises epileptic seizures, nutritive deficiency and HIV, though diabetes are most probable origin causes of formation.

In an exemplary specific embodiments, increasing plucked instrument soil can be used for treatment or prevents multiple sclerosis (MS) because of-modulating compound because of proteinic level and/or active plucked instrument soil, comprise recurrent MS and monosymptom MS, and other depletion of spirits are through the myelin patient's condition, and for example the depletion of spirit of chromium inflammatory through myelin polyneuropathy (chromic inflammatory demyelinating polyneuropathy) (CIDP) or the deficiency disorder related with it.

In another specific embodiments, increasing plucked instrument soil also can be used for treating neural wound, comprises because the wound that disease, damage (comprising the operation intervention) or environment wound (for example neurotoxin, alcoholism etc.) are caused because of-modulating compound because of proteinic level and/or active plucked instrument soil.

Increase plucked instrument soil because of proteinic level and/or active plucked instrument soil also can be used for because of-modulating compound, prevent, treat and alleviate the symptom of various PNS deficiency disorders.Term " peripheral DPN " comprises the nerve that wherein is positioned at brain and the spinal cord outside-periphery nerve-impaired deficiency disorder of wide scope.The periphery DPN also can refer to peripheral neuritis, if perhaps relate to manyly when neural, can use term polyneuropathy (polyneuropathy) or polyneuritis (polyneuritis).

Can increase plucked instrument soil comprises because of the PNS disease of proteinic level and/or active plucked instrument soil because of-modulating compound treatment: diabetes, leprosy, charcot-Marie-Tooth atrophy (Charcot-Marie-Toothdisease), acute infectious polyradiculoneuritis (Guillain-Barr é syndrome) and brachial plexus neuropathy (disease of the first chest root of neck and brachial plexus, nerve trunk, rope and periphery nerve composition).

In another embodiment, plucked instrument soil can be used for treatment or prevention poly glumine disease (polyglutamine disease) because of the reactivity compound.Exemplary poly glumine disease comprises myelitis marrow amyotrophy (Spinobulbar muscular atrophy) (kennedy's disease), Heng Dingdunshi disease (HD), dentation rubrum pallidal atrophy (Dentatorubral-pallidoluysian atrophy) (Hao crow river syndrome), marchi's bundle is done ataxia syndrome the 1st type (Spinocerebellar ataxia type 1), marchi's bundle is done ataxia syndrome the 2nd type, marchi's bundle is done ataxia syndrome the 3rd type (horse is added-Joseph disease), marchi's bundle is done ataxia syndrome the 6th type, marchi's bundle does ataxia syndrome the 7th type and marchi's bundle is done ataxia syndrome the 17th type.

In some specific embodiments, the invention provides a kind of treatment central nervous system cell, to prevent to lower to cell the method for the injury that causes because of blood flow.The injury severity that can be prevented depends on the cytotropic decreased extent of blood flow with major part typically, and the time length that reduces.In one embodiment, can prevent apoptosis or necrosis.In other specific embodiments, the injury that can prevent ischemic to mediate, for example cytotoxic edema or central nervous system tissue's anoxenia.In each specific embodiments, central nervous system cell can be cord cell or brain cell.

Comprise on the other hand plucked instrument soil is given individuality because of the reactivity compound administration, with the treatment central nervous system ischemia patient's condition.There are many central nervous system ischemia patient's condition can be by plucked instrument soil as herein described because of the reactivity compounds for treating.In one embodiment, the ischemia patient's condition is for causing any kind ischemia central nervous system injury, for example apoptosis or necrosis, cytotoxic edema or central nervous system tissue's anoxybiotic apoplexy.Apoplexy may be because of impacting any zone of brain, or by any generally notified cause the cause of disease that apoplexy takes place to be caused.During in this specific embodiments another selected, apoplexy was the brain stem apoplexy.During in this specific embodiments another selected, apoplexy was little cerebral apoplexy.In another selection again in this specific embodiments, apoplexy is an embolic stroke.During in this specific embodiments another selected, apoplexy was a hemorrhagic stroke.In other specific embodiments, apoplexy is the thrombus apoplexy.

Again on the other hand, but administration plucked instrument soil is because of the reactivity compound, to reduce the infraction size of ischemic core after the central nervous system ischemia patient's condition.And also administration plucked instrument soil with after the central nervous system ischemia patient's condition, reduces the size of ischemia penumbra or zone of transition band because of the reactivity compound valuably.

In one embodiment, medicinal composition can comprise and be used for the treatment of or prevent the neurodegenerative deficiency disorder course of treatment, or the medicine or the compound of the secondary patient's condition related with these patient's condition.Therefore, medicinal composition can comprise that one or more plucked instrument soil is because of activator and one or more anti--neurodegeneration agent the course of treatment.

The coagulation of blood deficiency disorder

In other respects, increase plucked instrument soil and can be used for because of-modulating compound, treatment or the preclude blood deficiency disorder (or the deficiency disorder that stops blooding) that condenses because of proteinic level and/or active plucked instrument soil.As being used for this paper convertibly, term " hemostasis ", " coagulation of blood " reach " blood clotting " and mean control and bleed, and comprise vasoconstriction and agglomerative physiological property.Coagulation of blood assists to keep the circulation integrity of Mammals after injured, inflammation, disease, birth defect, dysfunction or other are disintegrated (disruption).And being formed on of clot is not limited only to make blood flow (hemostasis) in the injured case, also may cause serious organ damage and death because of blocking important artery or vein aspect congee sample of blood pipe hardening disease.Therefore thrombus is the clot that forms in the time and the place of mistake.

So, the invention provides purpose and be to suppress clot and form, with the resist coagulation and the antithrombotic therapy of prevention or treatment coagulation of blood deficiency disorder (for example myocardial infarction, apoplexy, because of the amputation or the pulmonary infarction of peripheral arterial disease).

As being used for this paper convertibly, term " modulation hemostasis " reach " regulating hemostasis " and comprises and inducing (for example stimulate or increase), comprises that also inhibitions (for example lowering or minimizing) stop blooding.

On the one hand, the invention provides by administration increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, with lower or the inhibition individuality in the hematostatic method.Composition disclosed herein or method are useful on treatment or prevention thrombotic diseases.As being used for this paper, term " thrombus sexual maladjustment disease " comprises any with excessive or undesirable blood coagulation or styptic activity, or hypercoagulable state is the deficiency disorder or the patient's condition of feature.Thrombus sexual maladjustment disease comprises and relates to thrombocyte adhesiveness and thrombotic disease or deficiency disorder, and may be shown as the increase of thrombosed possibility, for example thrombus quantity increases, thrombus, familial tendency thrombosis occur in low age period, and forms thrombus at the exception position.

In another embodiment, medicinal composition can comprise to be used for the treatment of or preclude blood condense deficiency disorder or the medicine or the compound of the secondary patient's condition related with these patient's condition the course of treatment.Therefore, medicinal composition can comprise the course of treatment one or more increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of activator, resist-condense with one or more or resist-the thrombosis agent.

Weight management

On the other hand, increase plucked instrument soil and can be used for the weight increase or the obesity of treatment or prevention individuality because of-modulating compound because of proteinic level and/or active plucked instrument soil.For example, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound can (for example) be used for the treatment of or prevent the obesity that genetic obesity, alimentary obesity disease, hormone be correlated with, the obesity relevant with the administration medicine, be used to alleviate weight in patients or prevent the whose body weight increase.Have the individuality that needs this type of treatment can be fat for it, might become obesity, overweightly maybe might become overweight individuality.Might become fat or overweight individuality, can (for example) based on family's history, genetics, diet, activity level, ingestion of medicines, or its various various combinations are determined.

In other specific embodiments, can give because of-modulating compound administration because of proteinic level and/or active plucked instrument soil increasing plucked instrument soil, suffer from various other can be by promoting losing weight of individuality, and the disease and the patient's condition of being treated or preventing.This type of disease comprises (for example) hypertension, hyperpiesia, high blood cholesterol, hyperlipemia, diabetes B, insulin resistance, the glucose intolerance, hyperinsulinemia, coronary heart disease, stenocardia, congestive heart failure, apoplexy, gallbladdergallstonecholetithiasis, cholecystitis and chololithiasis, gout, osteoarthritis, obstructive sleep apnea and breathing problem, some types of cancer (carcinoma of endometrium for example, breast cancer, prostate cancer and colorectal carcinoma), pregnancy complications, the healthy variation of female reproduction (irregular menses for example, infertile, irregular ovulation), bladder control problem (for example stress incontinence); The uric acid nephrolithiasis; Moral ataxia disease (for example melancholy, diet out of control, figure's distortion and self-respect reduction).At last, the patient who suffers from AIDS can be because to the reaction of the combination treatment of AIDS, and develops into lipodystrophy or insulin resistance.

In another embodiment, increase plucked instrument soil, suppress lipogenesis or adipocyte and break up (in vitro or in vivo) because of proteinic level and/or active plucked instrument soil can be used for because of-modulating compound.These class methods can be used for treatment or obesity prevention.

In other specific embodiments, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil can be used for lowering appetite and/or increase satietion because of-modulating compound, cause by this to lose weight or avoid weight increase.There is the individuality that needs this type of treatment to can be overweight, fat individuality, or for might become overweight or fat individuality.This method comprised doses (form that for example is pill) every day, or per two days or weekly administration give individuality.Dosage can be " appetite attenuating dosage ".

In an exemplary specific embodiments, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can be by being used for the treatment of or preventing the combination treatment of weight increase or obesity to carry out administration.For example, one or more can be increased plucked instrument soil because of proteinic level and/or active plucked instrument soil because of activator, with one or more anti--fat agent combination medicine-feeding.

In another embodiment, but administration increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, to lower weight increase by the medicine initiation.For example, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can carry out administration by combination treatment with stimulateing appetite or cause weight increase (the especially weight increase that causes by the factor except reservation moisture content) medicine.

Metabolic disorder disease/diabetes

On the other hand, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can be used for treatment or prevent Metabolic disorder disease, for example insulin resistance, preceding-diabetic disease states, type ii diabetes and/or its complication.Increase plucked instrument soil because of the administration of proteinic level and/or active plucked instrument soil, can increase individual insulin sensitivity and/or attenuating insulin level because of-modulating compound.Having needs the individuality of this type of treatment can be, and has the prodrome of insulin resistance or other type ii diabetes, has type ii diabetes, maybe might develop into the individuality of any of these patient's condition.For example, individuality can be has insulin resistance, for example have the hyperinsulinism cyclical level and/or the patient's condition that is associated, for example hyperlipidemia, steatogenesis obstacle, hypercholesterolemia, glucose tolerance are impaired, the individuality of other signs, hypertension, atherosclerosis and the lipodystrophy of hyperglycemia level, syndrome X.

In an exemplary specific embodiments, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can or prevent in treatment carry out administration in the combination treatment of Metabolic disorder disease.For example, one or more can be increased plucked instrument soil because of proteinic level and/or active plucked instrument soil because of activator, with one or more anti--diabetes agent combination medicine-feeding.

Inflammatory diseases

In other respects, increase plucked instrument soil and can be used for disease that treatment or prevention are related with inflammation or deficiency disorder because of-modulating compound because of proteinic level and/or active plucked instrument soil.Can in cause inflammation begin preceding, simultaneously or administration afterwards increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound.When preventative use, compound was preferable over before any inflammatory reaction or symptom and provides.The administration of compound can prevent or weaken inflammatory reaction or symptom.

In another embodiment, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can be used for treatment or Ammonium Glycyrrhizate and breathe the patient's condition, comprise asthma, bronchitis, lung fibrosis, allergic rhinitis, oxygen toxicity, wind-puff, chronic bronchitis, adult respiratory distress syndrome and any chronic occlusion lung disease (COPD).Compound can be used for treating virus infection, comprises viral hepatitis type b and C type hepatitis.

In addition, increase plucked instrument soil and can be used for treating autoimmune disorders because of-modulating compound because of proteinic level and/or active plucked instrument soil, and/or the inflammation related, for example organ-tissues autoimmune disorders (for example Reynolds gets Cotard (Raynaud ' s syndrome)) with autoimmune disorders, scleroderma, myasthenia gravis, transplant rejection, endotoxin shock, septicemia, psoriasis, eczema, dermatitis, multiple sclerosis, the autoimmunity thyroiditis, uveitis, the whole body lupus erythematosus, Addison's disease (Addison ' sdisease), autoimmunity polyadenous disease (autoimmune polyglandular disease) (being also referred to as autoimmunity polyadenous syndrome) and Graves disease (Grave ' s disease).

In some specific embodiments, can adopt separately one or more increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, or be useful on other and treat or compounds of preventing inflammation are used in combination.

Flush (Flushing)

On the other hand, increase plucked instrument soil and can be used for the flush of attenuating deficiency disorder illness and/or the incidence or the severity of hectic fever (hot flash) because of-modulating compound because of proteinic level and/or active plucked instrument soil.For example, subject methods comprise use to increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound (separately or with other medicaments combinations), with attenuating cancer patients's the flush and/or the incidence or the severity of hectic fever.In other specific embodiments, the preparation of this method use increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, with women's the flush and/or the incidence or the severity of hectic fever after attenuating menelipsis and the menelipsis.

On the other hand, increase plucked instrument soil and can use conduct because of-modulating compound because of proteinic level and/or active plucked instrument soil, be the incidence of the flush of the illness of the side effect of another kind of pharmacotherapy and/or hectic fever (for example, medicine-bring out sexflush) or the therapy of severity in order to lower.In some specific embodiments, the method that is used for the treatment of and/or prophylactic agent-brings out sexflush comprises, to comprise at least a flush-bringing out property compound and at least a increase plucked instrument soil because of the composite of proteinic level and/or active plucked instrument soil because of-modulating compound, the patient of needs is given in administration.In other specific embodiments, the method that is used for the treatment of the flush that medicine brings out comprises, separate administration is brought out the compound of flush and one or more plucked instrument soil because of-modulating compound, (for example) wherein plucked instrument native because of-modulating compound and flush inducer without allocating in same composition.When using the composite that separates, can with plucked instrument soil because of-modulating compound (1) with the administration of flush inducer in, (2) at intermittence of flush inducer administration, (3) stagger with the administration of flush inducer, (4) before the administration of flush inducer, (5) be connected in after the administration of flush inducer, and (6) carry out administration with the form of its various various combinations.Exemplary flush inducer comprises (for example) nicotinic acid, method Lip river former times sweet smell (faloxifene), resist melancholy agent, anti--chlorpromazine, chemotherapeutic, calcium channel blocker and microbiotic.

In one embodiment, increase plucked instrument soil and can be used for the flush side effect of minimizing vasodilator or antilipemic (comprising Anticholesterolemic agent and lipotropic agent) because of-modulating compound because of proteinic level and/or active plucked instrument soil.In an exemplary specific embodiments, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, can be used for reducing the flush related with delivery of niacin.

In another embodiment, the invention provides the method that is used for the treatment of and/or prevents to have the hyperlipidemia that lowers the flush side effect.In another representative specific embodiments, this method comprise use to increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, with the flush side effect of minimizing raloxifene (raloxifene).In another representative specific embodiments, this method comprise use to increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, to reduce resist melancholy agent or to resist-the flush side effect of chlorpromazine.For example, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound can be used for and the serotonin reuptake inhibithors, or 5HT2 receptor's antagonist is in conjunction with (separating or administration together).

In some specific embodiments, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound can use as with the some of the treatment of serotonin reuptake inhibithors (SRI) with the minimizing flush.In another representative specific embodiments again, increase plucked instrument soil and can be used for reducing chemotherapeutic, for example flush side effect of endoxan and tamoxifen (tamoxifen) because of-modulating compound because of proteinic level and/or active plucked instrument soil.

In another embodiment, increase plucked instrument soil and can be used for reducing calcium channel blocker, for example flush side effect of amlodipine (amlodipine) because of-modulating compound because of proteinic level and/or active plucked instrument soil.

In another embodiment, increase plucked instrument soil and can be used for reducing antibiotic flush side effect because of-modulating compound because of proteinic level and/or active plucked instrument soil.For example, increasing plucked instrument soil can be used in combination with levofloxacin (levofloxacin) because of-modulating compound because of proteinic level and/or active plucked instrument soil.

The eye deficiency disorder

An aspect of of the present present invention, a kind of VI method of inhibition, attenuating or other treatment that is used for is provided, this method by with therapeutic dose the sirtuin modulators that is selected from compound disclosed herein, or the patient is given in its pharmaceutically acceptable salt, prodrug or metabolic derivative administration.

Of the present invention aspect some, vision impairment is because the injury of optic nerve or central nervous system is caused.In special specific embodiments, the optic nerve injury is caused by high intraocular pressure power (for example by glaucoma).In other special specific embodiments, the optic nerve injury is owing to neural swelling (it is often related with infection or immunity (for example autoimmunity) reaction, for example optic neuritis) institute causes.

Aspect some, vision impairment is caused by amphiblestroid injury of the present invention.In special specific embodiments, amphiblestroid injury is owing to the obstacle (for example, atherosclerosis, vasculitis) in the blood flow that flows to eyes causes.In special specific embodiments, amphiblestroid injury is because macula lutea is disintegrated (for example, exudative or non-exudative macular degeneration) and caused.

Exemplary amphiblestroid disease comprises, the exudative macular degeneration relevant with the age, the macular degeneration that the non-exudative age is relevant, retina electronics prosthese is transplanted relevant macular degeneration of age with RPE, the tabular pigment epithelium disease of acute many focuses, acute retinal necrosis, vitelliform macular degeneration (BestDisease), branch retinal artery occlusion (branch retinal artery occlusion), branch retinal vein occlusion (branch retinal vein occlusion), cancer association and relevant autoimmunization retinopathy (Cancer Associated and related Autoimmune Retinopathies), central retinal artery occlusion, central retinal vein occlusion, central serous chorioretinopathy (centralserous chorioretinopathy), eales disease (Eales disease), macula lutea cephacoria (epimacularmembrane), lattice degeneration (Lattice degeneration), huge aneurysma (macroaneurysm), diabetic macular edema, this macular edema of Ai Erwen-lid (Irvine-Gass Macular Edema), macular hole (macular hole), neovascularity film under the retina (subretinal NeovascularMembranes), diffuse unilateral subacute neuroretinitis (diffuse unilateral subacuteneuroretinitis), non-pseudophakia cystoid macular edema (nonpseudophakic cystoid macularedema), ocular histoplasmosis's syndrome of supposing (presumed ocular histoplasmosissyndrome), exudative detachment of retina, operation back detachment of retina, the hyperplasia detachment of retina, source, hole property detachment of retina, traction property (tractional) detachment of retina, retinitis pigmentosa, the CMV retinitis, retinoblastoma (retinoblastoma), retinopathy of prematurity, shot shape retinopathy (birdshot retinopathy), the background diabetic retinopathy, proliferative diabetic retinopathy, oxyphorase characteristic of disease retinopathy, the husky retinopathy (PurtscherRetinopathy) of pul, Wa Er Salva retinopathy (Valsalva Retinopathy), juvenile retinoschisis (juvenile retinoschisis), senile retinoschisis (senile retinoschisis), Tai Ersong syndrome (terson syndrome) and white point syndrome (white dot syndromes).

Other exemplary diseases comprise, the eye bacterial infection (for example, conjunctivitis, keratitis, tuberculosis, syphilis, gonorrhoea), virus infection (for example eye hsv, varicella zoster virus, the cytomegalovirus retinitis, human immunodeficiency virus (HIV)), and the inferior HIV of being born in or other HIV-are related and the outside retinal necrosis of the carrying out property of other immune deficiencies-cognation eye disease.In addition, eye disease comprises fungi infestation (for example candidiasis choroiditis, histoplasmosis), protozoal infections (for example toxoplasmosis) and other for example toxocariasis and sarcoidosis.

An aspect of of the present present invention is, be used for suppressing, lower or treat individuality and (for example carry out chemotherapeutic agent, the medicine of neurotoxicity medicine, rising intraocular pressure is steroid for example) the VI method in when treatment, its by with therapeutic dose sirtuin modulators administration disclosed herein give the individuality that this type of treatment needs.

Another aspect of the invention is, be used for suppressing, lower or treat individual undergoing surgery, comprise eye or other operations of carrying out in prone position (prone position), the VI method during operation on spinal cord for example, its by with therapeutic dose sirtuin modulators administration disclosed herein give the individuality that this type of treatment needs.Operated eye comprises cataract, iridotomy and lens displacement.

Another aspect of the invention is, treatment (comprise and suppressing and the prophylactic treatment) eye disease relevant with the age, comprise cataract, xerophthalmia, the age-method of relevant macular degeneration (AMD), retinal damage etc., its by with therapeutic dose sirtuin modulators administration disclosed herein give the individuality that this type of treatment needs.

Another aspect of the invention is, prevention or treatment are because of the infringement to eyes of pressure, chemistry injury or irradiation cause, and it is by the sirtuin modulators disclosed herein with therapeutic dose, and the individuality that this type of treatment needs is given in administration.Can comprise eyes irradiations or electro permanent magnetic infringement, by CRT or be exposed to those infringements that sunlight or UV cause.

In one embodiment, medicinal composition can comprise and be used for the treatment of or prevent the eye deficiency disorder course of treatment, or the medicine or the compound of the secondary patient's condition related with these patient's condition.Therefore, medicinal composition can comprise that one or more plucked instrument soil because of activator, is used for the treatment of or prevents the therapeutical agent of eye deficiency disorder with one or more the course of treatment.

In one embodiment, sirtuin modulators can be combined with therapy in order to reducing intraocular pressure power and carry out administration.In another embodiment, can with sirtuin modulators be used for the treatment of and/or prevent glaucomatous therapy to combine and carry out administration.In another embodiment, can with sirtuin modulators be used for the treatment of and/or prevent the therapy of ophthalmoneuritis to combine and carry out administration.In one embodiment, can with sirtuin modulators be used for the treatment of and/or prevent the therapy of CMV retinopathy to combine and carry out administration.In another embodiment, can with sirtuin modulators be used for the treatment of and/or prevent the therapy of multiple sclerosis to combine and carry out administration.

Plastosome-related disease and deficiency disorder

In some specific embodiments, the invention provides that be used for the treatment of can be because of increasing the disease that mitochondria activity benefits or the method for deficiency disorder.This method comprises the individuality that the plucked instrument soil of the last significant quantity of treatment is given needs because of the reactivity compound administration.Increasing mitochondria activity means, increasing mitochondrial activity keeps mitochondrial total number (for example mitochondrial quality) simultaneously, increases mitochondrial quantity and increases mitochondrial activity (for example, by stimulating mitochondrial biological the generation) or its combination thus.In some specific embodiments, can comprise disease related or deficiency disorder because of increasing disease or the deficiency disorder that mitochondria activity benefits with mitochondria dysfunction.

In some specific embodiments, be used for the treatment of and comprise and identify the individuality of suffering from mitochondria dysfunction because of increasing the disease that mitochondria activity benefits or the method for deficiency disorder.Be used for the handicapped method of diagnostics lines plastochondria, can comprise molecular genetics, pathology and/or biochemical analysis.Disease or the deficiency disorder related with mitochondria dysfunction comprise, the active deficiency of wherein mitochondrial respiratory chain causes the disease and the deficiency disorder of the physiopathology development of this type of disease in the Mammals or deficiency disorder.Can generally comprise (for example) because of increasing disease or the deficiency disorder that mitochondria activity benefits, by the tissue deterioration disease that the oxidative damage of free radical mediated causes, cell is the disease of apoptosis inadequately, and cell can't carry out the disease of apoptosis.

In some specific embodiments, the invention provides and be used for the treatment of meeting because of increasing mitochondria activity, and the disease that benefits or the method for deficiency disorder, comprise one or more plucked instrument soil because of reactivity compound and another kind of therapeutical agent, for example can be used for treating the medicament of mitochondria dysfunction, or can be used for reducing the medicament combination of the symptom related with disease that relates to mitochondria dysfunction or deficiency disorder, the individuality that needs is given in administration.

In an exemplary specific embodiments, the invention provides and be used for the treatment of and give individuality by the plucked instrument soil that will treat significant quantity because of the reactivity compound administration because of increasing the disease that mitochondria activity benefits or the method for deficiency disorder.Exemplary disease or deficiency disorder comprise that (for example the Buddhist Reed relies the Xi Shi ataxia to (for example) muscle nervous disorder disease, muscular dystrophy, multiple sclerosis etc.), (for example epileptic seizures of neurocyte unstable deficiency disorder, migraine etc.), hypoevolutism, neurodegenerative deficiency disorder (AIDS Alzheimer disease for example, Parkinson's disease, amyotrophic lateral sclerosis etc.), local asphyxia, renal tubular acidosis, nerve degeneration and cognitive decline that age is relevant, chemotherapy fatigue, the climacterium or menstrual cycle of relevant or phase chemotherapy induced of age or ovulate irregular, mitochondrial myopathy, plastosome infringement (for example calcium accumulation, excitotoxicity, nitrogen protoxide exposes, anoxic etc.) and plastosome go to regulate.

Muscular dystrophy is meant that gang relates to the disease of neuromuscular structure and function deterioration, and it often causes skeletal muscle atrophy and myocardial dysfunction, for example Duchenne's dystrophy (Duchenne musculardystrophy).In some specific embodiments, plucked instrument soil can be used for lowering the decay rates that muscle is carried out Functional Capability because of the reactivity compound, and is used to strengthen the functional status of suffering from muscular dystrophy patient muscle.

In some specific embodiments, plucked instrument soil can be used for treating mitochondrial myopathy because of modulating compound.The mitochondrial myopathy scope from outer eye muscle slightly, slowly carrying out property is weak, to serious, fatal infancy myopathy and multisystem brain myopathy.Some syndrome determines that some overlaps each other between them.The establishment syndrome that influences muscle comprises carrying out property exterior ocular myoplegia, Ke-Sai syndrome (Kearns-Sayre syndrome) (has ophthalmoplegia, the retinochrome pathology, the cardiac conduction defective, cerebellar ataxia and sensorineural hearing loss), MELAS syndrome (mitochondrial brain myopathy, lactic acidosis and apoplectic stroke incident), MERFF syndrome (myoclonia epileptica, the shred red fiber), limbus girdle distribute weak and infancy myopathy (optimum, severe is with deadly).

In some specific embodiments, plucked instrument soil can be used for because of the reactivity compound, and treatment is suffered from mitochondrial toxicity damage, for example because calcium accumulation, excitotoxicity, nitrogen protoxide expose, drug-induced toxicity damage, or the anoxybiotic patient.

In some specific embodiments, plucked instrument soil can be used for because of the reactivity compound, and treatment removes to regulate related disease or deficiency disorder with plastosome.

Muscle usefulness (Muscle Performance)

In other specific embodiments, the invention provides the method that is used for strengthen muscle usefulness, the plucked instrument soil by significant quantity on the drug treatment is because of the reactivity compound.For example, plucked instrument soil because of the reactivity compound can be used for improving health resisting power (for example, carry out that physical task is for example moved, health forced labour, motor activity etc.), suppresses or postpone physical fatigue, increases blood oxygen levels, the individual energy that improves health, strengthen work capacity with persistence, reduce muscle fatigue, reduce pressure, strengthen heart and cardiovascular function, improve sexuality, lactic acid in increase muscle ATP level and/or the minimizing blood.In some specific embodiments, this method comprises a certain amount of increase mitochondria activity of administration, promotes the plucked instrument soil of mitochondrial biological generation and/or increase mitochondrial mass because of the reactivity compound.

Sports performance efficiency means, the ability that athletic muscle can be carried out when participating in motor activity.Institute's enhanced sports performance efficiency, intensity, speed and stamina are increase, the increase of Muscle contraction amplitude, the shortenings of the muscle response time between between stimulation and contraction by mensuration Muscle contraction intensity, obtain.The sportsmen is meant with any degree and participates in motion, and seeks to reach the individual who promotes intensity, speed and resisting power level on its function for example vigorous and graceful family, cyclist, long distance race person, short distance racer etc.Institute's enhanced sports performance efficiency is shown by the ability that can overcome muscle fatigue, the ability that can keep the ability of long period vigor and have more effective exercise.

Sportsmen's muscle usefulness represent scope, be meant and may wish to produce the situation that permission plays or trains under secular higher patience degree.

Expect that method of the present invention also is effective in the relevant pathology patient's condition of treatment muscle, comprise that acute muscle reduces disease, for example amyotrophy and/or fix or main chest, belly and/or the related emaciation (cachexia) of plastic surgery operations with burn, bed, four limbs.

In some specific embodiments, the invention provides the new dietary composition (dietary composition) that comprises sirtuin modulators, its preparation method and use said composition are to improve the method for sports performance efficiency.So the present invention is to the motion that relates to through extensive definition, the people that comprise the motion that needs stamina and the labour of the repeated muscle utilization of needs provide has the health of improvement stamina, and/or therapeutic composition, the bag and bottle of the effect of inhibition physical fatigue.This type of dietary composition can additionally comprise ionogen, caffeine, VITAMIN, carbohydrate etc.

Other purposes

Increase plucked instrument soil and can be used for because of-modulating compound, treat or prophylaxis of viral infections (for example influenza virus, simplexvirus or parillomarvirus infections) or as anti-mycotic agent because of proteinic level and/or active plucked instrument soil.In some specific embodiments, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, the some that can be used as the medicinal composition therapy is carried out administration with the therapeutical agent that another kind is used for the treatment of virus disease.In another embodiment, increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, the some and the another kind of anti-mycotic agent that can be used as the medicinal composition therapy carry out administration.

The individuality that can as described hereinly treat comprises eukaryote, for example for example the mankind, sheep class, bovine, horse class, Swine, dog class, cat class, non-human primates, mouse and rat of Mammals.Liable cell comprises eukaryotic cell, for example derives from for example bacterial cell of aforementioned individual person or vegetable cell, yeast cell and prokaryotic cell prokaryocyte.For example, the modulating compound administration can be given farm-animals, to strengthen the ability that it can stand the farm situation more for a long time.

Increase plucked instrument soil because of proteinic level and/or active plucked instrument soil also can be used for because of-modulating compound, increase plant life, the pressure resistance reaches for apoptotic resistance.In one embodiment, compound (for example with periodic basis) is bestowed plant or fungi.In another embodiment, plant through genetic engineering to produce certain compound.In another embodiment, with plant and fruit before gathering and transporting earlier with this compound treatment, be increased in transport during for the resistance of damage.Also plant seed can be contacted with compound as herein described, make it anticorrosion with (for example).

In other specific embodiments, increase plucked instrument soil and can be used for regulating the life-span of yeast cell because of-modulating compound because of proteinic level and/or active plucked instrument soil.May wish that wherein the situation that prolongs the yeast cell life-span comprises, any in wherein using zymic technology, for example beer, sour milk and the manufacturing of curing project (for example bread).Use has the yeast of prolongs life, can reduce the zymic usage quantity, or it is longer to make yeast have the active time.Also can make proteinic yeast, or other mammalian cells carry out processing as described herein to being used for reorganization.

Increase plucked instrument soil because of proteinic level and/or active plucked instrument soil also can be used for because of-modulating compound, increase the insect life-span, the pressure resistance reaches for apoptotic resistance.In this specific embodiments, compound will be applied on the useful insect, and for example honeybee and other relate to the insect of plant pollination.In a special specific embodiments, compound will be administered to and relate to the honeybee of making honey.Generally, method as herein described may be used on any organism, for example has the eukaryote of commercial significance.For example, they can be applied to fish (aquaculture) and birds (for example chicken and poultry).

The increase plucked instrument soil that also can use higher dosage because of proteinic level and/or active plucked instrument soil because of-modulating compound is as sterilant, this is to be subjected to the adjusting of silencer by interference between the growth period, and realized by apoptotic adjusting.In this specific embodiments, can be by methods known in the art with this compound administration to plant, and guarantee this compound to insect larvae (and non-) for plant for biological available.

At least with regard to reproduction and the banded viewpoint between the life-span, can use increase plucked instrument soil because of proteinic level and/or active plucked instrument soil because of-modulating compound, influence Reproduction such as organisms such as insect, animal and microorganisms.

4. analyze

Dissimilarly describe to some extent because of active analytical procedure in order to measure plucked instrument soil to various.For example, plucked instrument soil can use with fluorescent because of activity and measure as based analyzing method, for example on the market can be available from the analytical procedure of Bai Oumo (Biomol), for example SIRT1 fluorescent mensuration medicine visualizingre agent box (Discoverykit) (AK-555), the SIRT2 fluorescent measures medicine visualizingre agent box (AK-556) or the SIRT3 fluorescent is measured medicine visualizingre agent box (AK-557) (the Bai Oumo world (Biomol International), Mao Si meeting in general PA) is measured.Other plucked instrument soil that are fit to disengage analysis (Ka Bailaien people such as (Kaeberlein) because of analysis comprises niacinamide, 17038 (2005)), FRET analyzes (Ma Kete people such as (Marcotte), Anal.Biochem.332:90 (2004)) and C J.Biol.Chem.280 (17): ¹⁴NAD boron resin binding analysis (Mai Ketangna people such as (McDonagh), Methods 36:346 (2005)).Other plucked instrument soil that are fit to also comprise radioimmunoassay (RIA), flicker proximate analysis (scintillation proximity assay) because of analyzing, based on analysis and the reporter gene analysis (the target thing that for example, is used for transcription factor) of HPLC.

It is a kind of that to be used to measure plucked instrument soil be the fluorescent polarographic analysis because of active exemplary analytical procedure.The fluorescent polarographic analysis is described in herein, and also through being described in the open case WO 2006/094239 of PCT.In other specific embodiments, plucked instrument soil can use with mass spectrometry because of activity and obtain as based analyzing method mensuration.With the mass spectrometry is the example description to some extent in this article of based analyzing method, and also is described among the open case WO 2007/064902 of PCT.Also can use with cell and measure plucked instrument soil because of activity as based analyzing method.Be used to measure plucked instrument soil because of active be the example of based analyzing method with the cell, be described among open case WO 2007/064902 of PCT and the WO 2008/060400.

Other desired herein methods comprise, be used to identify can regulate plucked instrument soil because of compound or the screening method of medicament.Medicament can be nucleic acid, for example fit (aptamer).Analysis can be carried out for basic or not celliferous form by cell.For example, analytical procedure can comprise plucked instrument soil because of cultivate (or contact) under the following conditions with test agent, this condition for therein can to plucked instrument soil because of by known regulate plucked instrument native because of reagent regulate, and in the presence of this test agent, monitor or measure with respect to the regulating degree that does not have under this test agent existence.Plucked instrument soil because of regulating degree can measure by its ability and obtain the substrate deacetylationization.Exemplary substrate is can be available from Bai Oumo (BIOMOL) (Mao Si meeting in general, PA) acetylated peptide class.Preferred substrate comprises the peptide class of p53, and for example those comprise the peptide class of acetylize K382.Especially preferred substrate is Fluor de Lys-SIRT1 (Bai Oumo), i.e. acetylated peptide Arg-His-Lys-Lys.Other substrates are peptide class or the acetylated amino acids that derives from human histone H 3 and H4.Substrate can be fluorescent.Plucked instrument soil is because of can be SIRT1, Sir2, SIRT3 or its part.For example, recombinant type SIRT1 can be available from Bai Oumo.Reaction can be carried out about 30 minutes, and (for example) stops with niacinamide.Can use HDAC fluorescent activation analysis/medicine visualizingre agent box (AK-500, Bai Oumo research laboratory) to measure degree of acetylation.Similarly analyze and be described in graceful people (2002) J.Biol.Chem.277:45099 such as (Bitterman) of bit.Can be with the plucked instrument soil in analyzing because of regulating degree, the plucked instrument soil of (it can be used as the positive or negative control group) compares because of regulating degree with there being one or more compound described herein (separating or the while) to exist down.The plucked instrument soil that is used to analyze is because of can be total length plucked instrument soil because of protein or its part.Because shown herein the reactivity compound as if can with the N-end effect of SIRT1, so the protein that is used to analyze comprise plucked instrument native because of N-end part, for example about amino acid/11-176 of SIRT1 or 1-255 part; The about amino acid/11-174 of Sir2 or 1-252 part.

In one embodiment, the screening method comprise (i) with plucked instrument soil because of with test agent and acetylize substrate, in the presence of this test agent of nothing and be suitable for making plucked instrument soil to contact under because of the condition that substrate is deacetylated; Reach the degree of acetylation of (ii) measuring substrate; the degree of acetylation of substrate in the presence of this test agent wherein; with respect to there not being low then expression in the presence of this test agent: this test agent stimulates by the deacetylated effect of plucked instrument soil because of carrying out; and in the presence of this test agent the degree of acetylation of substrate, do not have higher down then expression with respect to there being this test agent: this test agent suppresses by the deacetylated effect of plucked instrument soil because of carrying out.

Be used for identifying can in vivo regulate (for example stimulating) plucked instrument soil because of method can comprise (i) with cell and test agent and can enter the substrate of cell, in the presence of the inhibitor of I class and II class HDAC, be suitable for making plucked instrument soil because of in the presence of this test agent of nothing substrate being contacted under the deacetylated condition; Reach the degree of acetylation of (ii) measuring substrate; the degree of acetylation of substrate in the presence of this test agent wherein; do not have low down then expression with respect to there being this test agent: this test agent stimulates by the deacetylated effect of plucked instrument soil because of carrying out; and in the presence of this test agent the degree of acetylation of substrate, do not have higher down then expression with respect to there being this test agent: this test agent suppresses by the deacetylated effect of plucked instrument soil because of carrying out.Preferred substrate is the acetylated peptide class, and it also is preferably fluorescent, as further described substrate herein.This method can further comprise cytolysis, to measure the degree of acetylation of substrate.Can be with substrate with scope between about 1 μ M to about 10mM, preferably from about 10 μ M to 1mM, even more preferably from about 100 μ M to 1mM, the concentration of for example about 200 μ M adds in the cell.Preferred substrate is an acetylize Methionin, for example ε-ethanoyl Methionin (Fluor de Lys, FdL) or Fluor de Lys-SIRT1.The preferred inhibitors of I class and II class HDAC be Trichostatin A (trichostatin A, TSA), its can scope between about 0.01 μ M to 100 μ M, preferably from about 0.1 to 10 μ M, for example the concentration of 1 μ M is used.The cultivation of cell and test compounds and substrate can be carried out about 10 minutes to 5 hours, preferably about 1-3 hour.Because TSA suppresses all I classes and II class HDAC, and some substrate (for example Fluor de Lys) is relatively poor substrate for SIRT2, for SIRT3-7 even poorer, so alanysis can be used for identifying intravital SIRT1 conditioning agent.

5. pharmaceutical composition

Plucked instrument as herein described soil can pass through currently known methods because of-modulating compound, uses on one or more physiology acceptable carrier or vehicle to allocate.For example, plucked instrument soil can be through allocating because of acceptable salt on-modulating compound and the physiology thereof and solvate, and inject (for example SubQ, IM, IP) by (for example), suck or be blown into (through port or nose) or oral, oral cavity, hypogloeeis, carry out administration through skin, nose, parenteral or rectal administration.In one embodiment, plucked instrument soil can at the position of target cell existence, promptly carry out administration partly because of-modulating compound in particular organization, organ or body fluid (for example blood, celiolymph etc.).

Plucked instrument soil can be used for various form of medication through allotment, comprise whole body and part or regional administration because of-modulating compound.Technology and composite generally are found in Remington's Pharmaceutical Science, name enlightening publishing company, and Easton, PA (Remington ' s Pharmaceutical Sciences, Meade Publishing Co., Easton, PA).For the parenteral administration, preferred injection comprises intramuscular, intravenously, intraperitoneal and subcutaneous.Be used for injection, compound can be deployed into liquid solution, acceptable damping fluid on the preferred physiology is for example in Han Keshi solution (Hank ' s solution) or the Ringer's solution.Compound can be deployed into solid form in addition, and dissolving or suspension more immediately before using.Also can comprise freeze-dried.

For oral administration, pharmaceutical composition can for example be made by following form known: with pharmaceutically acceptable vehicle wedding agent (for example, in advance through W-Gum, Polyvinylpyrolidone (PVP) or the Vltra tears of gel) for example; Weighting agent (for example lactose, Microcrystalline Cellulose or secondary calcium phosphate); Lubricant (for example Magnesium Stearate, talcum or silica); Disintegrating agent (for example yam starch or sodium starch glycolate); Or wetting agent (for example Sodium Lauryl Sulphate BP/USP) tablet, lozenge or the capsular form that are prepared into.Tablet can coat by the method that this area has been known.The liquid preparation that is used for oral administration can adopt the form of (for example) solution, syrup or suspension, or they can show as before use the desciccate with water or other suitable media construction.This type of liquid preparation can be made by following form known: with pharmaceutically acceptable additive suspension agent (for example, Sorbitol Powder syrup, derivatived cellulose or hydrogenation edible lipid) for example; Emulsifying agent (for example Yelkin TTS or kordofan gum); Non-aqueous media (for example liking fourth oil (ationdoil), oily ester class, ethanol or classification vegetables oil); And sanitas (for example methyl or propyl group-right-hydroxybenzoate or Sorbic Acid).If suitably, preparation also can contain buffering salt, spices, tinting material and sweeting agent.The preparation that is used for oral administration can be allocated aptly, to realize controlled the disengaging of active compound.

For administration by suction (for example pulmonary delivery), can be easily with plucked instrument soil because of-modulating compound with from pressurized package or atomizer, follow use suitable propelling agent for example the aerosol spray form of Refrigerant 12, trichlorine list fluoromethane, dichloro tetrafluoro ethane, carbonic acid gas or other suitable gases send.In the case of pressurized aerosol, dose unit can decide by the valve that is provided for sending the amount of having measured.(for example) gelatine capsule or the cartridge case that are used for sucker or insufflator can be deployed into, and contain compound and suitable powder base, for example the powdered mixture of lactose or starch.

Plucked instrument soil can for example be realized the parenteral administration by large bolus injection or continous perfusion through allotment by injecting because of-modulating compound.The composite that is used to inject can present by unit dosage form, for example, is present in ampoule or the multi-dose container (the interpolation sanitas is arranged).Composition can adopt the form such as the suspension that has oiliness or aqueous media, solution or emulsion, and can contain allotment reagent for example suspension agent, stablizer and/or dispersion agent.Perhaps, active ingredient before use can be for suitable media, for example sterile pyrogen-free water processed powders form.

Plucked instrument soil also can be formulated into rectal compositions because of-modulating compound, and for example suppository or enema,retention for example contain known suppository substrate such as theobroma oil or other glyceride types.

Except previous described composite, plucked instrument soil also can be storage preparation (depot preparation) through allotment because of-modulating compound.This type of long-acting type composite can pass through to implant (for example with subcutaneous or intramuscular), or carries out administration via intramuscular injection.Therefore, for example, plucked instrument soil can be allocated because of-modulating compound and suitable polymer blend or hydrophobic material (for example being present in the emulsion that can accept in the oils) or ion exchange resin, or be the microsolubility derivative, for example be the microsolubility salt.The controlled form of disengaging also comprises paster (patch).

In some specific embodiments, compound as herein described can be used for through allotment, is delivered to central nervous system (CNS) and (summarizes in Bei Geli (Begley) pharmacy; Therapeutics (Pharmacology﹠amp; Therapeutics) 104:29-45 (2004)).Being used for the known approach that medicine is delivered to CNS comprises: Neurological Surgery strategy (for example intracerebral injection or Intraventricular perfusion); The molecule manipulation of reagent (for example, manufacturing comprises the mosaic type fused protein with the agent combination that has the transit peptides of affinity and itself can pass through BBB for the endothelial cell surface molecule) purpose is, approach is transported in the exploitation wherein endogenous of a kind of BBB; Design is in order to the pharmacy strategy (for example, water-soluble reagent being attached on lipid or the cholesterol carrier) of the liposolubility of increase reagent; And by high seepage force disintegrate of short duration destructions BBB integrity (by mannitol solution perfusion is gone into carotid artery, or the use biologically active agent for example angiotonin cause).

Liposome is the another kind of drug delivery system that can inject easily.So, also can be in the inventive method with the form administration of active compound with the liposome delivery system.Liposome has been known for those of ordinary skills.Liposome can by various phospholipid for example the stearylamide of cholesterol, phosphide Yelkin TTS class form.The liposome that can be used for the inventive method comprises all types liposome, comprises (but being not limited to) little unilamellar vesicle, big unilamellar vesicle and multilamellar vesicle.

The another kind of for example method of the composite of trans-resveratrol or derivatives thereof (especially solution) of sirtuin modulators of making is made by using cyclodextrin.Cyclodextrin mean α-, β-or γ-Huan Hujing.Cyclodextrin is described in detail in skin Sa people such as (Pitha), U.S.Pat.No.4, and in 727,064, it includes this paper in way of reference.Cyclodextrin is the cyclic oligomeric thing of glucose; These compounds and its molecular energy are engaged to any medicine in the lipophilic-search cavity (lipophile-seeking cavity) of cyclodextrin molecular and form and comprise complex compound (inclusion complex).

Disintegration or solvability dosage form can be used for fast, the rapid absorption of pharmaceutical active (especially oral cavity and hypogloeeis absorb).The dissolving dosage form is to having the representative solid dosage form of swallowing fast, and for example the patient of capsule and tablet difficulty (for example old and child patient) is useful.In addition, the dissolving dosage form has overcome (for example) shortcoming relevant with chewing dosage form fast, wherein, promoting agent keeps existing the time in patient's mouth to play an important role for the throat coarse grain sense aspect that determines sense of taste amount of covering and patient may experience promoting agent.

Pharmaceutical composition (comprising make-up composition) can comprise about 0.00001 to 100 weight %, and for example one or more of 0.001 to 10 weight % or 0.1 to 5 weight % plucked instrument as herein described soil is because of-modulating compound.

In one embodiment, plucked instrument as herein described soil is incorporated into, contained the topical carrier that generally is applicable to localized drug delivery, and comprise in the local composite of any this type of material known in the art because of-modulating compound.Can select topical carrier so that composition is desirable form, for example be ointment, washing lotion (lotion), breast frost, microemulsion, gel, oils, solution etc., and it can be made of the material in natural or synthetic source.Preferably, selected carrier can not influence other compositions of promoting agent or local composite nocuously.The topical carrier example that is suitable for this paper comprises, water, alcohols and other nontoxicity organic solvents, glycerine, mineral oil, silica, oil glue, lanolin, lipid acid, vegetables oil, benzoates, wax class etc.

Composite can be colourless, tasteless ointment, washing lotion, breast frost, microemulsion and gel.

Plucked instrument soil can be incorporated in the ointment that is generally semi-solid preparation because of-modulating compound, and it is substrate with oil or other petroleum derivatives typically.Use at the bottom of the special ointment base of (and those of ordinary skills understand), send for the suitableeest medicine can be provided, and other desired features and those of flexibility or similar characteristics for example preferably can be provided.If shared, then should be inertia, stable, nonirritant and non-sensitization at the bottom of the ointment base with other carriers or media.

Plucked instrument soil can be incorporated in the washing lotion because of-modulating compound, and it is generally desires to be applied to skin surface and the frictionless preparation, and be typically wherein solid particulate (comprising promoting agent) to be present in water or alcohols be the liquid state or the semi liquid state preparation of substrate.Washing lotion is generally solid suspension, and comprises the liquid oily emulsion of oil-in-water form.

Plucked instrument soil can be incorporated in the newborn frost because of-modulating compound, and it is generally liquid of vicidity or semi-solid state emulsion, is oil-in-water or water-in-oil-type.The white substrate of breast and contains oil phase, emulsifying agent and water for washing.Oil phase is generally by oil and Fatty Alcohol(C12-C14 and C12-C18), and for example hexadecanol or stearyl alcohol are formed; Water common (though and optionally) is excessive than oil phase on volume, and generally contains wetting agent.There is the emulsifying agent in the newborn white composite (as in aforementioned Lei Mingdun, explaining), is generally nonionic, anionic property, cationic or amphoterics.

Plucked instrument soil because of-modulating compound can be incorporated in the microemulsion, be generally two kinds and do not mix stable on the thermokineticss of liquid (for example oil and water) via the interfacial film stabilization of surfactant molecule, isotropic clarification dispersion liquid (pharmaceutical technology encyclopaedia (Encyclopedia of PharmaceuticalTechnology) (New York: Ma Sedike (Marcel Dekker) mutually, 1992), volume 9).

Plucked instrument soil can be incorporated in the gel composite because of-modulating compound, is generally the suspension of being made up of little inorganic particulate (two-phase system), or is uniformly distributed in the semi-solid systems that the big organic molecule of whole carrier liq (single-phase gels) is formed in fact.Though gel generally uses aqueous carrier, also can use alcohols and oils as carrier liq.

Also can comprise other promoting agents in the composite; for example other antiphlogistics, analgesic agent, biocide, anti-mycotic agent, microbiotic, VITAMIN, antioxidant reach the sun-block agent that generally is used for sun-proof composite; comprise (but being not limited to) cinnamyl o-aminobenzoate, benzophenone (especially benzophenone-3), camphor derivatives, laurate (for example octyl methoxycinnamate), phenyl phenacyl ketone class (for example PAROSOL 1789), Para-Aminobenzoic (PABA) and derivative thereof, and salicylate (for example octyl salicylate).

In some representative composite, promoting agent is at about 0.25 weight % to the 75 weight % that is this composite, be preferably about 0.25 weight % to 30 weight % of this composite, about 0.5 weight % to 15 weight % of this composite more preferably, and most preferably be in the scope of about 1.0 weight % to 10 weight % of this composite and exist.

The eye patient's condition can be passed through (for example) general, part, intraocular injection plucked instrument soil because of-modulating compound, or can disengage the native lasting releasing device because of-modulating compound of plucked instrument and treat or prevent by assigning.Can in pharmaceutically acceptable ophthalmology media, send because of-modulating compound because of proteinic level and/or active plucked instrument soil increasing plucked instrument soil, so that keeping contacting one section with the eye surface, compound is enough to allow compound penetrate the interior region of cornea and eyes, for example the time of cup, chamber, back, vitreum, aqueous humor, vitreous humor, cornea, iris/ciliary, lens, choroid/retina and sclera.Pharmaceutically acceptable ophthalmology media can for example be ointment, vegetables oil or adhesive material.Perhaps, The compounds of this invention can be injected directly in vitreous humor and the aqueous humor.In another is selected, but compound general administration (for example by intravenously perfusion or injection) is used for eye treatment.

Plucked instrument as herein described soil can be stored in the oxygen-free environment because of-modulating compound.For example, trans-resveratrol or its analogue can be prepared in airtight capsule for oral administration, for example (Pfizer is among Capsugel Inc.) available from Pfizer.

Can (for example) with the cell of plucked instrument soil because of-modulating compound extracorporeal treatment, carry out administration according to the method that is used for the graft administration is given individuality, it can follow for example cyclosporin A of (for example) administration immunosuppressive drug.General Principle about the medicine allotment, the reader can be with reference to cell therapy: stem cell transplantation (StemCell Transplantation), gene therapy (Gene Therapy) and cellular immunization therapy (CellularImmunotherapy), by G. Mo Sitanen (Morstyn); W. Xue Li steps on (Sheridan) and writes Cambridge University's publication, 1996; And the hematopoiesis stem cell therapy, E.D. bohr (Ball), J. Liszt (Lister) ﹠amp; P. Lip river (Law), mound gill Li Binsidun (Churchill Livingstone), 2000.

Plucked instrument soil can obtain by the medical program determination of the standard of being undertaken by cell culture or laboratory animal because of the toxicity and the therapeutic efficiency of-modulating compound.LD ₅₀Be to be lethal dosage for 50% group.ED ₅₀Be to go up effective dosage for treatment for 50% group.Dose ratio (LD between toxicity and therapeutic efficiency ₅₀/ ED ₅₀) be therapeutic index.The plucked instrument soil that preferably presents high therapeutic index is because of-modulating compound.Though can use the plucked instrument soil that has toxic side effect because of-modulating compound, the care should be used to design calmly to the delivery system of affected tissue, so that the injury for the uninfection cell can be minimized, and reduces side effect with this type of compound target thus.

Derive from the data of cell culture analysis and zooscopy, can be used for allocating dosage range for using the mankind.The dosage of this compounds can fall within and comprise having less or avirulent ED ₅₀In circulation composition (circulating concentration) scope of value.Dosage can be looked employed dosage form and the route of administration utilized and changing to some extent in this scope.For any compound, can treat according to the cell culture analysis and evaluation at first and go up effective dosage.Can be in zootype allocating dosage, comprise IC to reach it as being measured in cell culture ₅₀The circulating plasma concentration range of value (that is, test compounds reaches half-maximum inhibiting concentration to symptom).Such information can be used for more accurate mensuration and can be used for human dosage.Can (for example) by the level in the high-efficient liquid phase chromatogram technique measuring blood plasma.

6. test kit

Test kit also is provided herein, for example is used for the treatment of the test kit of purpose, or be used to regulate cell survival or regulate apoptotic test kit.Test kit can comprise one or more plucked instrument soil because of-modulating compound (for example, with the dosage of measurement) in advance.Test kit can randomly comprise, and is used for device and working instructions that cell is contacted with compound.Device comprises that syringe, support and other are in order to import plucked instrument soil in the individuality (for example blood vessel of individuality), or it is coated on the device of individual's skin because of-modulating compound.

In another embodiment, the invention provides a kind of composition of matter, it comprises plucked instrument of the present invention soil because of-modulating compound, with other treatment agent (with those identical therapeutical agents that are used for combination treatment and coupling composition), be present in other dosage form of branch, but they unite (associate) each other.Term " associating " each other is used for this paper and means, and will divide other dosage form packaging together, or not so attachment each other, thereby makes and can understand easily that these divide other dosage form to be sold, and desires the some that administration is the identical course of treatment.Preferably medicament is packaged in blister pack or other multicells packing with sirtuin modulators, or be can be connected by (for example, the tearing) that the user separates voluntarily by the delineation line place between two containers, the container of separately sealing (for example tinfoil paper pouch etc.).

In another specific embodiments, the invention provides a kind of a) plucked instrument soil of the present invention of existing in the container respectively of comprising because of-modulating compound; And b) another kind of therapeutical agent for example is described in the reagent of elsewhere in the specification sheets.

The enforcement of the inventive method will utilize (unless separately specify), cytobiology, cell cultures, molecular biology, genetically modified organism, microbiology, recombinant DNA and immunologic known technology known to those of ordinary skills.This type of technology is explained in document fully.Referring to (for example) molecular cloning laboratory manual A (Molecular Cloning A Laboratorymanual), the 2nd edition, write (research department, cold spring port publication: 1989) with Ma Niatisi (Maniatis) by mountain Brooker (Sambrook), sharp permitted (Fritsch) of Buddhist; Dna clone (DNA Cloning), volume I and II (D.N. Ge Luofo (Glover) writes 1985); Synthetic (Oligonucleotide Synthesis) (M.J. Gai Te (Gait) writes 1984) of few glycosides nucleic acid; This people U.S. patent No:4 such as (Mullis) in the curtain, 683,195; Nucleic acid hybridization (Nucleic AcidHybridization) (this (Hames) ﹠amp of B.D. Durham; S.J. Xi Jinsi (Higgins) writes 1984); Transcribe and translate (Transcription And Translation) (B.D. Durham Si ﹠amp; S.J. Xi Jinsi writes 1984); Animal cell culture (Culture of Animal Cells) (not auspicious Buddhist nun (Freshney), this (Liss) company limited in Ai Lan (Alan) R., 1987 of being permitted of R.I.); Immobilized cell and ferment (Immobilized Cells AndEnzymes) (IRL publishes, 1986); B. Pierre's ripple (Perbal), the implementation guide of molecular cloning (PracticalGuide To Molecular Cloning) (1984); Paper, (institute publishes company limited to Enzymology method (Methods InEnzymology), N.Y.); Mammalian cell is with gene transfer vector (GeneTransfer Vectors For Mammalian Cells) (J.H. Miller (Miller) and M.P. Caro this (Calos) are write, 1987, research department, cold spring port); Enzymology method (Methods In Enzymology), volume 154 and 155 (Wu people such as (Wu) writes), (Mai Er (Mayer) writes with fertile gram (Walker) for cell and molecular biological immuno-chemical method (Immunochemical Methods In Cell And Molecular Biology), institute publishes, London, 1987); Experiment immunization learns to do volume (Handbook ofExperimental Immunology), volume I-IV (D.M. Weir (Weir) writes 1986 with C.C. mine-laying kwell (Blackwell)); Operation mice embryonic (Manipulating the Mouse Embryo) (research department, cold spring port publishes, cold spring port, N.Y., 1986).

Embodiment

By only being explanation some aspect of the present invention and specific embodiments, and have no intention to limit by any way purpose of the present invention, the embodiment that is included in and be easier to understand the general description that the present invention is carried out with reference to following.

Embodiment 1

The preparation of N-(2-chloro-5-picoline-3-yl)-2-nitrobenzamide:

(13.65g 73.6mmol) dropwise adds under 0 ℃, and 5-amino-(9.54g 66.9mmol) is dissolved in the solution of pyridine (200mL) 6-chloro-3-picoline with the 2-nitrobenzoyl chloride.The mixture that is become is at room temperature stirred (18h).Then dark-coloured mixture is diluted with water (1500mL), and add saturated sodium bicarbonate solution up to pH value arrival 8.To precipitate by filtering and collect, it is also dry to wash (30mL * 3) with water, thereby must be solid N-(2-chloro-5-picoline-3-yl)-2-nitrobenzamide (17.70g, the productive rate: 91%) of light color.

The also preparation of [5,4-b] pyridine of 6-methyl-2-(2-nitrophenyl) thiazole:

Will the N-in the pyridine (50mL) (2-chloro-5-picoline-3-yl)-2-nitrobenzamide (5.0g, 17.1mmol) and P ₂S ₅(7.6g, 34.2mmol) and the mixture of p-dimethylbenzene (200mL) stir down (20h) in 140 ℃.Solvent is removed in vacuum.Resistates is carried out purifying by recrystallize from EtOH, thereby must be also [5,4-b] pyridine (3.5g, productive rate: 75%) of xanchromatic solid 6-methyl-2-(2-nitrophenyl) thiazole.

The also preparation of [5,4-b] pyridine of 6-(brooethyl)-2-(2-nitrophenyl) thiazole:

Under argon gas, with 6-methyl-2-(2-nitrophenyl) thiazole also [5,4-b] pyridine (2.9g, 10.7mmol), N-bromosuccinimide (NBS, 1.91g, 10.7mmol), CCl ₄(200mL) be mixed in the three-necked flask (500mL) with benzoyl peroxide (0.021g).The yellow mixture that obtains is stirred (2h) under refluxing.Extra NBS (1.91g) is added with benzoyl peroxide (0.021g).After treating under refluxing, to stir 2 hours in addition again, once more NBS (0.95g) is added with benzoyl peroxide (0.021g), and mixture was refluxed 3 hours.Make mixture be cooled to room temperature, and in vacuum, concentrate and rough 6-(brooethyl)-2-(2-nitrophenyl) thiazole [5,4-b] pyridines (4.0g) also, it is directly used in next step.

The preparation of 4-((2-(2-nitrophenyl) thiazole is [5,4-b] pyridine-6-yl also) methyl) piperazine-1-carboxylic acid tert-butyl ester:

With rough 6-(brooethyl)-2-(2-nitrophenyl) thiazole also [5,4-b] pyridines (4.0g), Boc-piperazine (1.99g, 10.7mmol), triethylamine (Et ₃N) (1.5mL, 10.7mmol) with acetonitrile (100mL), (4h) and stirring (60h) under room temperature under 50 ℃.The TLC proved response is finished.Mixture is concentrated in vacuum, and by silica gel tomography (sherwood oil: ethyl acetate: Et ₃N=100: 10: 1) carry out purifying, and must be yellow solid 4-((2-(2-nitrophenyl) thiazole is [5,4-b] pyridine-6-yl also) methyl) piperazine-1-carboxylic acid tert-butyl ester (3.6g, productive rate: 74%, go through 2 steps).

The preparation of 4-((2-(2-aminophenyl) thiazole is [5,4-b] pyridine-6-yl also) methyl) piperazine-1-carboxylic acid tert-butyl ester:

To contain 4-((2-(2-nitrophenyl) thiazole is [5,4-b] pyridine-6-yl also) methyl) piperazine-1-carboxylic acid tert-butyl ester (2.13g, 4.7mmol), NH ₄Cl (2.00g, 37mmol), iron powder (1.31g, 23.5mmol), H ₂The mixture of O (40mL) and methyl alcohol (160mL) is in N ₂Under refluxed 3 hours.Reaction mixture is filtered, and filtrate is concentrated in vacuum, and by silica gel tomography (sherwood oil: ethyl acetate: Et ₃N=800: 200: 1) carries out purifying, thereby must be xanchromatic solid 4-((2-(2-aminophenyl) thiazole is [5,4-b] pyridine-6-yl also) methyl) piperazine-1-carboxylic acid tert-butyl ester (1.63g, productive rate: 81%).

For the aniline intermediate of compound 1-6,11-43,45,47-61,65,67-68,72,74-75,77-88,90,92-122,127-130, be with as the preceding similar approach that is outlined, use suitable amine reagent preparation to obtain.

The preparation of N-(2-(6-(piperazine-1-ylmethyl) thiazole is [5,4-b] pyridine-2-yl also) phenyl)-3-(1H-tetrazolium-5-yl) benzamide:

With 4-((2-(2-aminophenyl) thiazole also [5,4-b] pyridine-6-yl) methyl) piperazine-1-carboxylic acid tert-butyl ester (85mg, 0.2mmol) be absorbed in the DMF of 3mL, and 3-(1H-tetrazolium-5-yl) phenylformic acid (38mg, 0.2mmol), HATU (114mg, 0.3mmol) with DIEA (35mL, 0.4mmol) in.Reaction mixture is stirred (18h) down in 50 ℃.Then it is diluted with EtOAc (15mL), and wash (3mL * 3) with the water collection.With organic layer drying (Na ₂SO ₄) and in vacuum, concentrate, thereby get rough 4-((2-(2-(3-(1H-tetrazolium-5-yl) benzamido) phenyl) thiazole is [5,4-b] pyridine-6-yl also) methyl) piperazine-1-carboxylic acid tert-butyl ester.With this material absorbing in the 25%TFA of 5mL in CH ₂Cl ₂In, and make it be statically placed in (18h) under the room temperature.Reaction mixture is concentrated in vacuum, and resistates is carried out purifying by anti-phase HPLC, thereby must be flaxen solid N-(2-(6-(piperazine-1-ylmethyl) thiazole is [5,4-b] pyridine-2-yl also) phenyl)-3-(1H-tetrazolium-5-yl) benzamide. ¹H?NMR(300MHz，DMSO-d ₆)δ9.5(br?s，2H)，7.5-9.1(m，10H)，4.5(br?s，1H)，3.5-4.0(m，10H)。MS (ESI) is for C ₂₅H ₂₃N ₉The calculated value of OS (m/z): 497.17, experimental value: 498.2 (M+1) ⁺

The compound that all are discussed in this patent is with as the preceding similar approach that is outlined, and uses suitable acids to prepare.These do not contain the product of BOC-protecting group, do not pass through TFA and go to protect step.

Embodiment 2

The preparation of 1-methyl-4-phenyl-1H-pyrroles-2-carboxylic acid:

Under argon gas, in regular turn with Pd (PPh ₃) ₄(0.66g, 0.58mmol) with phenyl-boron dihydroxide (3.46g, 28.4mmol) add to methyl-4-bromo-1-methyl isophthalic acid H-pyrroles-2-carboxylicesters (2.5g, 11.5mmol) be dissolved in DMF (35mL) in stirred solution.Reaction mixture is heated to 70 ℃, and with the Na of water-soluble (30mL) ₂CO ₃(11g 104mmol) adds.Reaction mixture is heated to, and 110 ℃ (14h) is cooled to room temperature, dilutes with water (250mL), and washes (250mL * 3) with the ether collection.With make up organic layer dry and in vacuum, concentrate.With resistates by the silica tomography (with sherwood oil: ethyl acetate=40: 1 dissolveds) carry out purifying, thereby the crystalline form solid 1-methyl-4-phenyl-1H-pyrroles-2-carboxylicesters (0.257g) that must be white in color.Then with this ester (0.26g, 1.2mmol) and LiOH/H ₂(0.15g 3.6mmol) is mixed in THF (5mL), CH to O ₃OH (5mL) and H ₂Among the O (2.5mL), and in 40 ℃ of stirrings (4h) down.Water (25mL) is added, and mixture is washed with DCM (15mL) collection.Use HCl (1N) that the pH value of water is adjusted to 5-7.Water is removed, and resistates is dissolved in filtration then among the MeOH (100mL).Filtrate is concentrated in vacuum, thus the solid 1-methyl that must be white in color-4-phenyl-1H-pyrroles-2-carboxylic acid.(0.419g) ¹H-NMR(CDCl3，400MHz)：δ4.01(s，3H)，7.16(d，J＝1.6Hz，1H)，7.23(t，J＝7.2Hz，1H)，7.38(m，3H)，7.53(dd，J＝7.2，8.4Hz，2H)

Embodiment 3

The preparation of 2-phenyl isonicotine acid:

(2.02g 10mmol) is dissolved among the DMF (80mL) with 2-bromine niacin under nitrogen.With Pd (PPh ₃) ₄(0.6g 0.52mmol) adds, and reaction mixture was stirred under room temperature 15 minutes.Then with Na ₂CO ₃(aq.2N 40mL) adds, and (1.67g 13.7mmol) adds with phenyl-boron dihydroxide subsequently.Reaction mixture in 95 ℃ of heating (18h) down, is cooled to room temperature and passes through the filtration of celite (celite) filter bed.Water (80mL) is added, and mixture is acidified to pH=4 with HCl (2N).To precipitate via filtering collection and washing (2 * 7mL) with water.With raw product recrystallize from 2-methyl cellosolve, thereby get grizzly solid 2-phenyl isonicotine acid (1.2g). ¹HNMR(DMSO-d6，400MHz)：δ7.51(m，3H)，7.78(d，J＝4.8Hz，1H)，8.13(t，J＝1.6Hz，2H)，8.29(s，1H)，8.85(d，J＝4.8Hz，1H)，13.73(bs，1H)。

Embodiment 4

Biologic activity

Use with mass spectroscopy and identify the active conditioning agent of SIRT1 as based analyzing method.Analysis based on mass spectroscopy is to utilize; peptide class with following 20 amino-acid residues: Ac-EE-K (vitamin H)-GQSTSSHSK (Ac) NleSTEG-K (5TMR)-EE-NH2 (SEQ ID NO:1); wherein K (Ac) is the acetylize lysine residue, and Nle is a nor-leucine.Peptide is demarcated in C-and held with fluorophorre 5TMR (exciting 540nm/ emission 580nm).The sequence of this peptide substrates is based on the p53's with the modification of number place.Methionine(Met) in addition, the methionine residues that is present in natively in this sequence is replaced into nor-leucine, because may carry out oxidation easily during synthetic and purifying.

Carry out the spectrometer analysis method as follows: with 0.5M peptide substrates and 120 μ M β NAD ⁺With 10nM SIRT1 under 25 ℃, in reaction buffer (50mM Tris-acetate pH8,137mMNaCl, 2.7mM KCl, 1mM MgCl ₂, 5mM DTT, 0.05%BSA) the middle cultivation 25 minutes.Test compounds can be added in the reaction as described above.The SirT1 gene clone in the carrier that contains the T7 promotor, and is transformed into it among BL21 (DE3).After cultivating 25 minutes, 10% formic acid of 10 μ L is dropwise added with termination reaction with SIRT1.To react sealing and freezing to be used for carrying out after a while mass spectroscopy.The quality determination of peptide substrate make with acetylated peptide (product) when comparing, can accurately measure degree of acetylation (being initial substance).

500mM niacinamide by adding 1 μ L when reaction (for example allow measure maximum plucked instrument soil because of the restraining effect) beginning is as negative control group, thereby obtains the control group of plucked instrument soil because of activity inhibition.Use 10nM plucked instrument soil because of protein,,, thereby obtain the control group of plucked instrument soil because of active activation with the deacetylated amount of mensuration substrate in the given time point in the linearity range inherence of this analysis with the DMSO alternative compounds of 1 μ L.The time point of this time point when being used for test compounds is identical, and, in linearity range, the variation of terminal point representation speed.

For aforementioned analysis, SIRT1 protein is expressed and purifying according to as described below.The SirT1 gene clone in the carrier that contains the T7 promotor, and is transformed into it among BL21 (DE3).With spend the night under the 18 ℃ expression of induced protein of 1mMIPTG, and expressed protein is N-end His-tag fused protein, and in 30,000 * g results down.With N,O-Diacetylmuramidase with cytolysis in the dissolving damping fluid (50mMTris-HCl, 2mM Tris[2-propyloic] phosphine (TCEP), 10 μ M ZnCl ₂, 200mM NaCl) in, and further handle 10 minutes with dissolving fully with the ultrasound concussion.Protein is passed through Ni-NTA post (Ai Moxun (Amersham)) purifying, and compile the part that contains true protein, concentrate and process big or small fraction post (Sephadex S20026/60 is spherical).Collection contains the peak of soluble protein, and carries out purifying on ion exchange column (MonoQ).(200mM-500mM NaCl) obtains true protein by the gradient dissolved.This protein is concentrated, and carry out dialysed overnight with dialysis buffer liquid (20mM Tris-HCl, 2mM TCEP).With the protein five equilibrium and be frozen under-80 ℃ up to further use.

Use plucked instrument soil that aforementioned Analysis and Identification goes out to activate SIRT1 because of-modulating compound, and it is shown in the following table 3.EC _1.5On behalf of test compounds, value have to make the concentration of the effect of SIRT1 activation 150%.NT means this compound and does not use specified analysis to test.NA means this compound and do not have an activity in specified analysis.In table 3, also indicated the maximum activation per-cent multiple of SIRT1.

Table 3

Coordinator

The present invention provide particularly plucked instrument soil because of-reactivity compound and using method thereof.Though discussed the special specific embodiment of the present invention, aforementioned specification is not to be used to limit the present invention for exemplifying explanation only.Many variants of the present invention will become conspicuous after consulting this specification sheets for those of ordinary skills.Full breadth of the present invention should be represented by the scope of claims and the full breadth of coordinator thereof, and be decided by specification sheets and this type of variant.

Incorporate into way of reference

Open and patent text mentioned herein comprises these hereinafter listed projects, and incorporates into its integrity way of reference that for example each open text or granted patent text are to incorporate among the application with way of reference especially and all.Under inconsistent situation, will be limited to the application's content (comprising any definition herein).

Also be with what the way of reference of its integrity was incorporated into, any reference is relevant to the polynucleotide and the peptide sequence of the login numbering that enters the open source information storehouse, for example those by genome research association (TIGR) (www.tigr.org) and/or biotechnology resource center (NCBI) (www.ncbi.nlm.nih.gov) possessed those.

Also with way of reference incorporate into for following: the open case WO 2005/002672 of PCT; 2005/002555 and 2004/016726.

Claims (29)

1. the compound or its salt class of structural formula (II) expression,

Wherein:

X ¹To X ⁴In two be selected from-CR ^*-and-N-;

X ¹To X ⁴In other two be-CR ^*-;

R ^*Be independently selected from when occurring-H at every turn, low carbon number alkyl or halogen;

R ¹Be solubilizing group; And

R ²Be selected from optional through one or more be independently selected from-CN ,-F ,-Cl and-CF ₃The phenyl that replaces of substituting group, and work as X ¹To X ⁴Respectively be-CR ^*-time, R ²Be selected from extraly and contain N heteroatoms and second heteroatomic 5-to the 6-element heterocycle that randomly is selected from N, O or S, wherein this heterocycle is optional through methyl substituted.

2. according to the compound of claim 1, wherein:

X ¹To X ⁴For-CR ^*-; And

R ²Be selected from phenyl, fluorophenyl, difluorophenyl, chloro-phenyl-, difluorophenyl methylthiazol base, pyrimidyl, pyridyl and pyrazolyl.

3. according to the compound of claim 2, R wherein ²Be selected from phenyl, fluorophenyl, difluorophenyl, chloro-phenyl-, 2-methylthiazol-4-base, pyridyl and pyrazol-1-yl.

4. according to the compound of claim 3, R wherein ²Be phenyl or pyridyl.

5. according to the compound of claim 1, X wherein ¹To X ⁴In one be-N-.

6. according to the compound of claim 1, X wherein ¹To X ⁴In two be-N-.

7. according to the compound of claim 5, X wherein ¹Be N.

8. according to the compound of claim 6, X wherein ¹With X ²For-N-.

9. according to the compound of claim 6, X wherein ¹With X ⁴For-N-.

10. according to each compound in the claim 1 to 9, wherein:

R ¹For-CH ₂-R ³And

R ³Be selected from C for optional through one or more ₁-C ₄Alkyl, amino, halogen, methoxyl group and methoxyl group-C ₁-C ₄The nitrogen heterocyclic ring that the substituting group of-alkyl replaces.

11. according to the compound of claim 10, wherein R ²Be phenyl, pyridyl or 3-fluorophenyl.

12. according to the compound of claim 11, wherein X ²With X ³For-CH-and X ¹With X ⁴Be independently selected from-CR ^*-or-N-.

13. according to the compound of claim 10, wherein:

R ¹For-CH ₂-R ³, and

R ³Be selected from piperazine-1-base, 4-(methoxy ethyl-piperazine-1-base, 3,5-lupetazin-1-base, morpholine-4-base, piperidines-1-base, 4-amino piperidine-1-base, tetramethyleneimine-1-base, 3-fluoropyrrolidine-1-base ,-NH-(tetramethyleneimine-3-yl) and 1,4-phenodiazine-dicyclo [2.2.1] heptan-1-base.

14. according to the compound of claim 13, wherein R ³Be selected from 4-(methoxy ethyl)-piperazine-1-base, morpholine-4-base, piperidines-1-base and 4-amino piperidine-1-base.

15. according to the compound of claim 14, wherein R ²Be phenyl, 3-fluorophenyl or pyridyl.

16. according to the compound of claim 15, wherein X ²With X ³For-CH-and X ¹With X ⁴Be independently selected from-CR ^*-or-N-.

17. according to the compound of claim 1, wherein R ^*Be H.

18. according to the compound of claim 1, be compound or its salt class by formula (IV) expression,

Wherein:

X parameter is selected from-CH-and-N-;

Other two X parameters are-CH-;

R ¹Be solubilizing group; And

R ²Be selected from phenyl or fluorophenyl, and when the X parameter be-during CH-, R ²Be selected from extraly and contain N heteroatoms and second heteroatomic 5-to the 6-element heterocycle that randomly is selected from N, O or S, wherein this heterocycle is optional through methyl substituted.

19. the compound or its salt class of representing by the structure formula V,

Wherein:

Ring A is selected from:

R ¹Be solubilizing group; And

R ^#For-H or-O-CH ₃

20. by the compound or its salt class of structural formula (VI) expression,

Wherein:

Ring B is selected from:

R ¹Be solubilizing group.

21. a pyrogen-free composition, it comprises in the claim 1 to 20 each compound or its pharmaceutically acceptable salt and carrier.

22. a pharmaceutical composition, it comprises in the claim 1 to 20 each compound and pharmaceutically acceptable carrier.

23. according to the pharmaceutical composition of claim 22, it further comprises extra promoting agent.

24. treatment is suffered from or suffered from easily the individuality of insulin resistance, metabolism syndrome, diabetes or its complication or is used to increase the method for individual insulin sensitivity, described method comprises to the described pharmaceutical composition of individual administration claim 22 that needs are arranged.

25. method according to claim 24, wherein this compound increases plucked instrument soil because of in proteinic level or the activity at least one.

26. method according to claim 25, wherein this compound increases plucked instrument soil because of proteinic deacetylation enzymic activity.

27. method according to claim 25, wherein this plucked instrument soil is mammalian proteins matter because of protein.

28. method according to claim 25, wherein this plucked instrument soil is human SIRT1 because of protein.

29. method according to claim 25; wherein this compound effectively increases under SIR1 and/or the active concentration of the proteinic deacetylation of SIRT3 at this compound, does not have following one or more activity in fact: suppress the PI3-kinases, suppress the alditol reductase enzyme, suppress Tyrosylprotein kinase, Transactivation EGFR Tyrosylprotein kinase, coronary artery expansion or separate the spasm activity.